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 Macrophages and dendritic cells (DCs) play an essential role during mycobacterial infection, 
acting as key effector cells in bacterial killing and antigen presentation. Cathepsins are host proteases 
involved in pathogen destruction and antigen presentation. This makes these proteases, as well as 
both cell types, perfect targets for mycobacterial manipulation.  
  In the first part of this thesis the role of mycobacteria during macrophage activation and DC 
maturation was addressed. By flow cytometry the surface expression of activation and maturation 
markers of mycobacteria infected human macrophages and DCs, was analyzed. It was demonstrated 
that: (1) M. tuberculosis H37Ra prevents the induction of the classical activated macrophage 
phenotype; (2) induces the maturation process of immature DCs; (3) the outcome of infection with M. 
tuberculosis H37Ra differs from that with M. smegmatis. These results indicate that M. tuberculosis 
infection has a differential role during macrophage activation and DC maturation and that M. 
tuberculosis H37Ra interferes with these processes differently of the non-pathogenic M. smegmatis.  
 In the second part, we aimed to decipher the role of cathepsins during mycobateria infection of 
macrophages and DCs. Cathepsins protein levels were analyzed by western blot after infection with 
pathogenic or non-pathogenic mycobacteria. It was shown that cathepsin B and S levels during M. 
tuberculosis infection are distinct from those of host cells that internalized M. smegmatis and this is 
dependent on the host cell species tested. In addition, the role of these proteases in M. tuberculosis 
intracellular survival was evaluated by silencing cathepsins expression, using shRNA lentiviral vectors. 
It was observed, that cathepsin B and S knockdowns led to an increase in M. tuberculosis H37Ra 
intracellular survival. Altogether, these evidences point for a role of both cathepsins in the control of M. 
tuberculosis intracellular growth and demonstrate that M. tuberculosis modulates these cathepsins 


















 A tuberculose representa um dos mais graves problemas de saúde pública, causando 
anualmente cerca de dois milhões de mortes em todo o mundo. Estima-se que cerca de um terço da 
população mundial se encontra infectada com Mycobacterium tuberculosis, o microrganismo 
patogénico causador desta doença infecciosa. A emergência de estirpes de M. tuberculosis 
multirresistentes e extensivamente resistentes à terapêutica antibiótica utilizada, aliado ao facto de a 
única vacina disponível possuir baixa eficácia contra a tuberculose pulmonar, vem realçar a 
necessidade urgente de se encontrar novos alvos terapêuticos e novas estratégias para controlar a 
doença.  
 O sucesso deste patogénio reside, principalmente, na sua capacidade de sobreviver e de se 
dividir no interior de células imunitárias. Após ser internalizado pelos macrófagos, M. tuberculosis 
inibe a fusão do fagossoma com o lisossoma, escapando assim à acção das enzimas proteolíticas 
(catepsinas) e ao ambiente acídico do fagolisossoma. Em paralelo, os macrófagos infectados 
induzem uma resposta pró-inflamatória, que promove o recrutamento de células imunitárias da 
corrente sanguínea para o local da infecção. Forma-se o granuloma, a estrutura característica da 
tuberculose, que se pensa ser capaz de conter a infecção micobacteriana. Aqui, algumas 
micobactérias podem permanecer num estado de latência durante um longo período de tempo. 
Apenas 5 a 10% da população infectada desenvolve a doença activa, o que na maioria dos casos se 
deve a uma imunodepressão do hospedeiro.  
 Nos pulmões, M. tuberculosis é internalizado por macrófagos alveolares residentes, mas 
também por células dendríticas recrutadas da corrente sanguínea. Estes dois tipos de células 
apresentadoras de antigénios desempenham papéis distintos na imunidade contra a tuberculose. Os 
macrófagos ao induzirem os seus mecanismos bactericidas são os principais responsáveis pela 
destruição das micobactérias. Por outro lado, as células dendríticas são especializadas na 
apresentação de antigénios micobacterianos às células T naïve, que se encontram nos nódulos 
linfáticos. De modo a conseguirem desempenhar estas funções, é necessário que ocorra um 
processo de activação dos macrófagos assim como um processo de maturação das células 
dendríticas. Estudos anteriores mostram que as micobactérias têm a capacidade de interferir com 
estes processos.  
 As catepsinas são proteases que estão envolvidas num grande número de processos 
celulares em macrófagos e células dendríticas, tais como: destruição dos patogénios, processamento 
e apresentação de antigénios, processamento de várias enzimas celulares do hospedeiro e também 
apoptose. O seu vasto número de funções, e em particular o seu papel na destruição dos patogénios 
e na apresentação de antigénios, faz destas proteases alvos perfeitos para manipulação por 
micobactérias durante a infecção de macrófagos e células dendríticas.  
 Na primeira parte desta tese, é explorado o papel das micobactérias durante a activação dos 
macrófagos e a maturação das células dendríticas. Foram infectados macrófagos e células 
dendríticas, diferenciados a partir de monócitos isolados do sangue periférico de dadores humanos 
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saudáveis, com micobactérias que expressavam a proteína verde fluorescente (GFP), 
nomeadamente a estirpe avirulenta M. tuberculosis H37Ra GFP e a espécie não patogénica M. 
smegmatis. Através de citometria de fluxo, foram seleccionadas apenas as células infectadas com 
micobactérias fluorescentes e o efeito da infecção foi analisado pela medição da expressão de 
marcadores superficiais de activação e maturação. Ao infectar macrófagos não activados (M0) com 
M. tuberculosis H37Ra, verificou-se que a infecção impede a indução da clássica resposta pró-
inflamatória M1, ao nível das moléculas apresentadoras de antigénios. Pelo contrário, a infecção de 
macrófagos M0 com M. smegmatis tem um efeito estimulatório, resultando num fenótipo idêntico ao 
induzido pela estimulação destas células com interferão-gama. Tendo em conta que o número de 
células infectadas com M. tuberculosis H37Ra GFP e com M. smegmatis GFP é semelhante, 
podemos concluir que as diferenças observadas ao nível dos marcadores de activação resultam, 
efectivamente, de diferenças de virulência entre ambas as espécies. Por outro lado, a infecção de 
macrófagos previamente estimulados com interferão-gama (M1), com M. tuberculosis H37Ra, não 
inibiu a activação destas células, pelo menos ao nível das moléculas apresentadoras de antigénios. 
Isto sugere que, com uma baixa multiplicidade de infecção, a activação induzida pelo interferão-gama 
consegue superar os mecanismos inibidores induzidos pelo M. tuberculosis H37Ra, ao nível das 
moléculas apresentadoras de antigénios.  
 Relativamente às células dendríticas, verificou-se que a infecção com M. tuberculosis H37Ra 
induz a maturação das células dendríticas imaturas, uma vez que se observou um aumento da 
expressão das moléculas apresentadoras de antigénios nas células infectadas. Foi também 
observado um aumento da expressão destes marcadores de maturação, após a infecção com M. 
smegmatis. No entanto, observou-se uma maior indução da maturação, pela estirpe avirulenta M. 
tuberculosis H37Ra, do que pela espécie saprófita M. smegmatis. As diferenças na virulência entre 
estas duas espécies poderão justificar o facto da infecção com M. tuberculosis H37Ra ser muito mais 
estimulatória do que com M. smegmatis. Estas evidências levam-nos a especular que a maturação 
das células dendríticas, observada após a infecção com M. tuberculosis H37Ra, poderá representar 
uma forma da micobactéria tirar partido das características migratórias das células dendríticas 
maturas e assim se disseminar pelo hospedeiro. Outra possível explicação seria que a indução da 
maturação pela infecção constitui um mecanismo de defesa do hospedeiro, na medida em que as 
células dendríticas infectadas representam fortes estimuladores das células T CD4+.   
 Concluindo, verifica-se que a infecção com a estirpe avirulenta M. tuberculosis H37Ra induz 
diferentes fenótipos, de acordo com o tipo de célula hospedeira infectada. Isto provavelmente está 
relacionado com as diferentes funções dos macrófagos e das células dendríticas na resposta imune 
contra a tuberculose. Em macrófagos humanos, esta estirpe avirulenta impede a expressão do 
fenótipo M1, ao nível das moléculas apresentadoras de antigénios, o que indica que provavelmente 
induz um fenótipo anti-inflamatório. Nas células dendríticas, a indução da maturação após a infecção 
com M. tuberculosis H37Ra pode reflectir um modo de disseminação utilizado pela micobactéria, ou 
um mecanismo de defesa do hospedeiro que lhe permita iniciar uma resposta imune celular 
específica. Para além disto, a infecção M. tuberculosis H37Ra induziu fenótipos distintos nas células 
imunes, comparativamente a M. smegmatis.  
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 Na segunda parte desta tese, foi abordado o papel das catepsinas durante a infecção 
micobacteriana de macrófagos e células dendríticas. Focámos o nosso estudo nas catepsinas S e B, 
as quais estão envolvidas na apresentação de antigénios via moléculas MHC classe II. A expressão 
destas catepsinas foi avaliada ao nível das proteínas, em macrófagos e células dendríticas infectados 
com a estirpe virulenta M. tuberculosis H37Rv ou com a espécie não patogénica M. smegmatis, de 
forma a analisar se a infecção por micobactérias modula a expressão destas proteases. Demonstrou-
se que, em macrófagos M0, a infecção com M. tuberculosis H37Rv diminui a expressão das 
catepsinas S e B, enquanto que com M. smegmatis não provoca qualquer alteração nestas 
proteases.  
 Por outro lado, a infecção micobacteriana afectou de forma diferencial a expressão das 
catepsinas S e B em células dendríticas e macrófagos humanos. Verificou-se que a infecção, tanto 
com M. tuberculosis H37Rv como com M. smegmatis, parece não interferir com os níveis de 
catepsina B nas células dendríticas. Relativamente à catepsina S, observou-se um aumento dos seus 
níveis após a infecção, tanto com M. tuberculosis H37Rv como com M. smegmatis. A infecção de 
células dendríticas imaturas com a estirpe virulenta resultou num aumento mínimo dos níveis de 
catepsina S, enquanto que a infecção de células dendríticas maturas resultou num grande aumento 
dos níveis desta protease. Apesar de não termos uma clara explicação para estes resultados, 
especulamos que, nas células dendríticas imaturas, M. tuberculosis H37Rv impede o aumento dos 
níveis de catepsina S, interferindo assim com apresentação de antigénios. Apesar de estas células 
após a infecção adquirirem um fenótipo de maturas, como anteriormente descrito, as moléculas 
apresentadoras de antigénios que estas expressam, encontram-se provavelmente num estado 
imaturo. Por outro lado, as células dendríticas maturas parecem ser capazes de superar este efeito 
inibitório e por isso se observa um grande aumento dos níveis desta protease.  
 Em paralelo, fomos também explorar o papel das catepsinas S e B na sobrevivência 
intracelular de M. tuberculosis em macrófagos. Para isso, monócitos humanos THP-1 foram 
silenciados para estas catepsinas, através do uso de vectores lentivirais a expressar short hairpin 
RNAs. Posteriormente, estas células foram diferenciadas em macrófagos e estes foram infectados 
com a estirpe virulenta M. tuberculosis H37Rv ou com a estirpe avirulenta M. tuberculosis H37Ra. Ao 
analisar os perfis de sobrevivência, verificou-se que o silenciamento da catepsina S aumenta 
significativamente a sobrevivência intracelular de M. tuberculosis H37Ra, enquanto que parece não 
interferir com a sobrevivência intracelular de M. tuberculosis H37Rv. Tendo em conta que a estirpe 
virulenta parece ter a capacidade de manipular a catepsina S em macrófagos humanos, é provável 
que o seu silenciamento mimetize esta modulação e, como tal, não se observem alterações na sua 
sobrevivência relativamente ao controlo sem silenciamento. A catepsina S parece ser relevante para 
o controlo do crescimento intracelular de M. tuberculosis H37Ra, mas enquanto a estirpe virulenta M. 
tuberculosis H37Rv parece desenvolver um mecanismo para evitar o efeito desta protease, a estirpe 
avirulenta M. tuberculosis H37Ra, parece não desenvolver o mesmo mecanismo de manipulação ou 
então desenvolve mas é menos efectivo. Foi também demonstrado que o silenciamento da catepsina 
B em macrófagos aumenta significativamente a sobrevivência intracelular de M. tuberculosis H37Ra e 
de M. tuberculosis H37Rv. Isto evidencia um papel desta protease no controlo da sobrevivência 
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intracelular de ambas as estirpes em macrófagos.  
 Concluindo, verificou-se que os níveis de catepsina S e B, durante a infecção com M. 
tuberculosis H37Rv, são diferentes dos observados durante a infecção com M. smegmatis. Para além 
disso, também se observou que os níveis de catepsina S e B diferem consoante a espécie das 
células imunitárias infectadas, o que poderá estar relacionado com diferentes cinéticas de 
acidificação e de actividade proteolítica existentes entre elas. Para além disto, os resultados mostram 
um papel de ambas as catepsinas no controlo do crescimento intracelular de M. tuberculosis H37Ra e 
M. tuberculosis H37Rv em macrófagos. Porém, a estirpe virulenta M. tuberculosis H37Rv parece ser 
capaz de subverter os efeitos bactericidas da catepsina S, ao diminuir os seus níveis proteicos. No 
entanto, a estirpe avirulenta M. tuberculosis H37Ra parece ser mais susceptível aos efeitos de ambas 
















Mycobacterium tuberculosis, Mycobacterium smegmatis, macrófagos, células dendríticas, catepsinas, 










 Tuberculosis, one of the oldest recorded human diseases, is considered one of the leading 
causes of infectious disease mortality worldwide (Daniel, 2006; WHO, 2012). During the first half of the 
XIX century, this disease was the leading cause of death in Europe, as a result of the population 
explosion and the growth of large urban centers. The only treatment then, which consisted of fresh air, 
a good healthy diet and rest, was available in the so called sanatoriums (Harries et al., 2006; Smith, 
2003). The first microbiological advances in this disease were made when the German physician 
Robert Koch first identified the tubercle bacillus, in 1882 (Barry III and Cheung, 2009). During the XX 
century, the incidence of tuberculosis was greatly reduced in the developed countries, due to the 
improvement of public health practices, the widespread use of the live attenuated M. bovis BCG 
(Bacillus Calmette-Guérin) vaccine, as well as the discovery of antibiotics, such as streptomycin, the 
first effective therapy for tuberculosis. By that time, many experts believed that tuberculosis had been 
nearly eradicated. However, in the mid-1980s the number of new cases increased with the 
deterioration of socio-economic conditions and the emergence of Human Immunodeficiency Virus 
(HIV), especially in southern and east Africa (Barry III and Cheung, 2009; Smith, 2003). This lead in 
1993, to the World Health Organization to declare the disease as a global emergency (Harries et al., 
2006).  
 Nowadays, tuberculosis still remains a major public-health problem with one-third of world’s 
population infected with Mycobacterium tuberculosis and 8.7 million new cases of tuberculosis 
reported, in 2011 (World Health Organization, 2012). Although tuberculosis still causes almost two 
million deaths annually worldwide, the disease particularly affects developing regions such as Africa, 
which has the highest proportion of tuberculosis cases co-infected with HIV (Corbett et al., 2003; 
Smith, 2003; World Health Organization, 2012). The currently available BCG vaccine, which provides 
protection against the disease in childhood, has proven to be ineffective against the most frequent 
outcome of tuberculosis, the lung infection in adults (Soualhine et al., 2007). This situation became 
even more alarming with the emergence of multidrug and extremely drug-resistant strains of M. 
tuberculosis worldwide (Nguyen and Pieters, 2009). Therefore, new strategies for the prevention and 
treatment of tuberculosis are urgently needed. A better understanding of the mechanisms of 
interaction between M. tuberculosis and the host immune system is crucial to define novel therapeutic 




 The genus Mycobacterium comprises rod-shape bacteria characterized by a very complex 
lipid-rich cell envelope that differs substantially from the typical cell wall structure of gram-positive and 
also gram-negative bacteria. The cell envelope contains, in addition to the cell membrane and 
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peptidoglycan layers, a large hydrophobic layer composed by mycolic acids associated to a vast array 
of other lipids and glycolipids (Forrellad et al., 2013; Glickman et al., 2001; Russell, 2001). This unique 
envelope confers intrinsic resistance to antibiotics and dehydration being also responsible for the acid-
fast staining property used to identify mycobacteria, in Zhiel-Neelsen acid-fast stain (Forrellad et al. 
2013; Scherr and Nguyen, 2009). The majority of the species that compose the genus are non-
pathogenic environmental bacteria, such as Mycobacterium smegmatis, which presents similarities to 
soil bacteria from the genus Streptomyces (Cosma et al., 2003; Scherr and Nguyen, 2009). However, 
a few species are highly successful pathogens including Mycobacterium leprae, Mycobacterium 
ulcerans and those present in the Mycobacterium tuberculosis complex.  
 The Mycobacterium tuberculosis complex consists in a group of genetically closely related 
species namely Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, 
Mycobacterium microti, Mycobacterium canetti, Mycobacterium caprae and Mycobacterium pinnipedii 
(van Soolingen et al., 1997; Aranaz et al., 1999; Aranaz et al., 2003; Cosma et al., 2003; Cousins et 
al., 2003), which are the etiologic agents of tuberculosis in humans and other animals. Although, all 
the members of the complex are facultative intracellular pathogens that cause tuberculosis, they 
diverge in terms of their phenotypic properties, host tropisms and virulence (Ahmad, 2011). The most 
well known member is Mycobacterium tuberculosis, a slow-growing and obligate aerobe bacterium, 
which the only known natural host is the human species (Cosma et al., 2003; Pieters, 2001). 
 
1.3. Pathogenesis of Tuberculosis  
  
 Tuberculosis is usually a lung infection but may affect almost any organ of the body. This 
infection is caused by inhalation of aerosols containing the infectious bacilli, generated from the cough 
of an infected individual which has developed the active respiratory disease (Mortellaro et al. 2009). In 
the lung, M. tuberculosis is internalized by resident alveolar macrophages but also by dendritic cells 
and monocytes recruited from the bloodstream (Bhatt and Salgame, 2007). Once inside 
macrophages, M. tuberculosis subverts the major killing mechanisms employed by these host cells 
(Hestvik et al., 2005; Smith, 2003). This pathogen prevents fusion of phagosomes with lysosomes 
(Armstrong and Hart, 1971) and restricts its phagosome acidification to a mild pH (Sturgill-Koszycki et 
al., 1994), escaping from the degrading forces of proteolytic enzymes and from an acidic environment 
inside the phagolysosome. Therefore, the bacilli have the capacity to avoid immediate destruction, 
which allows them to establish a niche inside the macrophage (Houben et al., 2006).  
 Simultaneously, the M. tuberculosis infected macrophages induce a localized pro-
inflammatory response, through the release of cytokines and chemokines, which promotes the 
recruitment of additional macrophages and other immune cells from the neighboring blood vessels to 
the infection site. These cells are the building blocks for the granuloma, the hallmark structure of 
tuberculosis (Dietrich and Doherty, 2009; Russell, 2007). The granuloma is constituted by an 
organized cluster of immune cells composed by infected macrophages in the center, surrounded by 
additional macrophages and lymphocytes, which delineate the periphery of the structure in association 
with a fibrous extracellular matrix. Dentritic cells, neutrophils and natural killer cells may also populate 
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this structure (Cosma et al., 2003; Russell, 2007). Although the precise function of the granuloma is 
not completely understood, it is believed that the formation of this structure contributes to the physical 
containment of the mycobacterial infection, limiting the pathogen dissemination to the rest of the lung 
tissue (Ahmad, 2011; Forrellad et al., 2012). However, the pathogen is not completely eradicated in 
some individuals since some M. tuberculosis bacilli may remain dormant for a long period of time, 
during which there are no disease symptoms and the individual does not transmit the infection to 
others. In this stage the infection is referred to as latent tuberculosis (Ahmad, 2011; Forrellad et al., 
2012; Smith, 2003). Thus, only 5-10% of the infected population will develop the active disease in their 
lifetime (Mortellaro et al., 2009). When the immune system of a latently infected individual becomes 
weakened as a consequence of malnutrition, old age or HIV co-infection, the dormant bacilli are able 
to reactivate and replicate into the lung and other tissues (Ahmad, 2011). Under this situation, the 
granuloma center becomes necrotic, undergoes caseation, resulting in the destruction of the 
surrounding host tissue (Houben et al., 2006). This leads to the rupture of the granuloma walls and to 
the release of infectious bacilli into the airways (Dietrich et al., 2009; Russell, 2007).  
 
1.4. Interaction of mycobacteria with antigen presenting cells 
 
 The interaction of mycobacteria with antigen presenting cells (APCs) is a major feature in the 
pathogenesis of tuberculosis. Both macrophages and dendritic cells play a central role in inducing the 
immune response against M. tuberculosis infection. Macrophages act as key effector cells in 
mycobacterial killing and dendritic cells in mycobacterial antigen presentation and consequent 
stimulation of naïve T cells. Therefore, both cell types are perfect targets for mycobacterial induced 
manipulation (Hope et al., 2004; Mortellaro et al., 2009). 
 
1.4.1. Macrophages as the main reservoir for mycobacteria 
 
 Macrophages constitute the first line of cellular defense against microbial invasion and are 
known to be the main reservoir of infection by M. tuberculosis. Upon reaching the local of infection, the 
major role of macrophages is the rapid elimination of the invading microorganisms (Hestvik et al., 
2005; Russell, 2001). A variety of cell surface receptors promote M. tuberculosis phagocytosis, these 
include among others, complement receptors, the mannose receptor (MR) and Fc receptors (Pieters, 
2008). Following uptake, M. tuberculosis and other pathogens are retained within a phagocytic 
vacuole called the phagosome. If the normal phagosome maturation cycle occurs, a series of 
sequential fusion events with vesicles from the endocytic pathway occur, the phagosome fuses with 
lysosome and the pathogen encounters a hostile environment that includes acidic pH levels, reactive 
oxygen (ROI) and nitrogen intermediates (RNI) and lysosomal proteases, such as cathepsins. 
Together, these mechanisms will promote the pathogen destruction as well as the processing and 
presentation of antigens to T cells, in the context of major histocompatibility complex (MHC) molecules 
(Hope et al., 2004; Poirier and Av-Gay, 2012).  
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 Contrasting with this scenario, pathogenic mycobacteria have developed strategies to avoid 
these killing mechanisms (Hestvik et al., 2005; Smith, 2003). Armstrong and Hart (1971) showed that 
after being phagocytosed, M. tuberculosis arrests normal maturation of its phagosome and thus 
prevents its fusion with pre-formed lysosomes, avoiding direct exposure of the bacilli to the degrading 
force of lysosomal hydrolases. Moreover, phagosomes containing M. tuberculosis do not undergo 
further acidification, presenting a mild pH of 6.2- 6.3, due to the exclusion of vacuolar proton-ATPase 
from the bacilli-containing phagosome membrane (Sturgill-Koszycki et al., 1994; Tailleux et al., 2003). 
These mechanisms not only allow the bacilli to evade proteolytic degradation but also contribute to 
keeping its antigens from being processed and loaded onto MHC class II molecules for antigen 
presentation (Baena and Porcelli, 2009). In addition to interfering with phagosome maturation, M. 
tuberculosis also manipulates intracellular trafficking in macrophages, retaining access to the recycling 
endosome system, in order to obtain the required nutrients for the bacilli intracellular growth (Clemens, 
1996; Mortellaro et al., 2009). 
  
Macrophage activation and its consequences during M. tuberculosis infection 
 
 In response to pathogen invasion and inflammation mediators, resting macrophages (M0) 
undergo different programs of activation (polarization). Activated macrophages have been generally 
classified into two groups: classical (M1) and alternative (M2) activated macrophages (Benoit et al., 
2008). M1 macrophages result from the stimulation with type-1 cytokines (Interferon gamma - IFN-γ) 
and microbial products. These cells are inflammatory and their microbicidal activity is enhanced (Lugo-
Villarino et al., 2011). In contrast, M2 macrophages are poorly microbicidal and play a critical role in 
the resolution of inflammation by producing anti-inflammatory mediators. M2 activation program is 
driven by the stimulation of resting macrophages with type-2 cytokines, interleukin 4 (IL-4) and 
interleukin 13 (IL-13). In general, polarization of M1 macrophages is part of the common host immune 
response against bacterial infection (Andrade et al., 2012; Benoit et al., 2008).  
 In resting macrophages, pathogenic mycobacteria in order to survive and replicate, inhibit 
phagosome-lysosome fusion. However, IFN-γ activated macrophages (M1) are able to overcome the 
blockage of phagosome maturation from infected cells. Furthermore, IFN-γ activated macrophage 
response is characterized by the secretion of large amounts of pro-inflammatory cytokines and 
chemokines, high production of ROI and RNI, and enhanced phagocytosis. It also enhances the 
expression of MHC class II and costimulatory molecules such as CD80 and CD86 for antigen 
presentation to T cells (Herbst et al., 2011; Lugo-Villarino et al., 2011; Poirier and Av-Gay, 2012).  
 
Antigen presentation pathway and their modulation by M. tuberculosis 
 
 Once activated by IFN-γ, macrophages have the capacity to present mycobacterial antigens to 
T cells. However, unlike dendritic cells which present mycobacterial antigens to naïve T cells in lymph 




  Antigen presentation mediated by MHC molecules is a complex process that involves 
distinctive pathways. MHC class I molecules are expressed on all nucleated cells, presenting antigens 
to antigen-specific CD8+ T cells. This pathway is specialized to present endogenous antigens, which 
are processed in the cytosol via proteasome. In contrast, MHC class II molecules expression is 
restricted to the professional APCs, including macrophages, dendritic cells and B cells. This pathway 
allows the presentation of exogenous antigens, such as mycobacterial antigens, that are processed in 
the endosomal route and presented to CD4+ T cells (Crevel et al., 2002; Hsing and Rudensky, 2005). 
Moreover, there is another antigen presentation pathway involved. Nonclassical MHC-like molecules, 
such as CD1, present among others lipids, mycobacterial lipoproteins to CD1-restricted T cells, and 
are expressed on both macrophages and dendritic cells (Crevel et al., 2002). Besides this, dendritic cells 
and macrophages are also capable of performing cross-presentation. This pathway enables 
presentation of peptides derived from exogenous antigens on MHC class I molecules and consequent 
stimulation of CD8+ T-cells (Rock and Shen, 2005).  
 CD4+ T cell activation is essential for control of mycobacterial infection, therefore interfering 
with MHC class II pathway for antigen presentation in macrophages, might be a strategy employed by 
the bacterium to avoid destruction and to persist in host immune cells (Chapman, 2006; Koul et al., 
2004). Indeed, several mechanisms have been described by which M. tuberculosis can affect antigen 
presentation, including downregulation of the expression of MHC class II and costimulatory molecules, 
and sequestering mycobacterial antigens from molecules required for CD4+ T-cell activation (Koul et 
al., 2004; Noss et al., 2000; Russell, 2001). Components of mycobacterial cell wall, such as the 19-
kDa lipoprotein, down-regulate surface expression of MHC class II molecules, reducing the antigen 
presentation capacity of the infected macrophages (Noss et al., 2001). Furthermore, mycobacterial 
species were found to interfere with macrophage IFN-γ signaling in order to inhibit the synthesis of 
MHC class II molecules (Noss et al., 2000).  
 
 
1.4.2. Dendritic cells as important targets during mycobacteria infection 
 
 Dendritic cells (DCs) are the most potent antigen presenting cells of immune system, given 
their unique ability to capture the pathogen at the infection site and to migrate to secondary lymphoid 
organs in order to present pathogen-derived antigens to naïve T-cells. Hence, they are likely to have a 
major role in initiation of the adaptive immunity against tuberculosis (Banchereau et al., 2000; 
Herrmann and Lagrange, 2005; Savina, 2007).  
 Dendritic cells are monocytic bone marrow derived cells, present in most peripheral tissues 
such as the skin, intestine and the lungs, where they act as sentinel cells, monitoring the contact of the 
body surfaces with incoming pathogens (Demangel and Britton, 2000; Hope et al., 2004). In these 
sites, they are considered as immature dendritic cells. They express low to moderate levels of surface 
MHC class II and co-stimulatory molecules such as CD40, CD80, CD86, while having a high capability 
to phagocyte invading microorganisms. Therefore, immature dendritic cells are characterized by a high 
ability for antigen uptake, but low T cell stimulatory activity (Hope et al., 2004; Martino, 2008). In the 
lungs, immature dendritic cells underline alveolar spaces and upon mycobacterial encounter, these 
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cells effectively uptake the M. tuberculosis bacilli (Hanekom et al., 2003; Mortellaro et al., 2009). Upon 
interaction with pathogens, tissue injury or exposure to inflammatory mediators, these efficient antigen 
capturing cells undergo phenotypic and functional changes, a process termed maturation, that occur 
while they migrate into secondary lymphoid organs such as lymph nodes. During this maturation 
process, dendritic cells lose the capability to capture antigens, but acquire an increased ability to 
present antigens effectively, expressing high levels of antigen presenting molecules in their surface, 
such as MHC class II and CD1, and high levels of co-stimulatory molecules as CD40, CD80 and CD86 
(Banchereau et al., 2000; Martino, 2008). In lymph nodes, mature dendritic cells present processed 
antigens in association with MHC class II molecules to naïve CD4+ T lymphocytes, inducing their 
activation and differentiation into effector T cells (Figure 1).  
  
 
 Depending on the type of pathogen that is recognized by the dendritic cells and on the 
cytokine environment, CD4+ T cells differentiate into T helper 1 (Th1) cells which secret IFN-γ, 
inducing the killing of intracellular pathogens or T helper 2 (Th2) cells characterized by the production 
of interleukin 4 (IL-4), effective against extracellular pathogens (Koul et al., 2004). During M. 
tuberculosis infection, the Type 1 cytokines IL-12, IL-1 and IL-18 are secreted, polarizing the T cell 
response towards Th1 phenotype (Mortellaro et al., 2009). Thus, the effector Th1 cells, activated 
following antigen presentation by dendritic cells, migrate to the site of infection and produce cytokines 
such as IFN-γ in order to activate M. tuberculosis infected macrophages and consequently eliminate 
the bacilli (Bodnar et al., 2001; Poirier and Av-Gay, 2012).  
 Because dendritic cells play a crucial role in induction and regulation of a protective immunity 
against pathogens, modulation of dendritic cell generation and/or maturation may be a significant 
mechanism by which these infectious agents evade immune surveillance and disseminate within the 
host (Martino et al., 2004). Considerable in vitro evidence exists that dendritic cells can internalize 
pathogenic mycobacteria by phagocytosis (Henderson et al., 1997), although the outcome of this 
Figure 1.  Role of dendritic cells (DC) in the immune system. In peripheral tissues, immature DCs, act as 
sentinel cells, monitoring these tissues against invading pathogens. Upon pathogen capture, immature DCs 
initiate their maturation and migration through the lymph into lymph nodes.  Pathogen-derived antigens are 
presented by the mature DCs to naïve CD4+ T cells, inducing their activation and differentiation into effector T 
cells. This figure was adapted from Geijtenbeek et al. (2002).  
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interaction is still not completely understood. In particular, the ability of these pathogens to interfere 
with dendritic cell maturation remains controversial. Henderson et al. (1997) found that human 
monocyte-derived dendritic cells uptake M. tuberculosis efficiently, promoting the up-regulation of cell 
surface maturation markers in infected cells, including surface molecules involved in antigen 
presentation and interaction with T cells. This phenotype was consistent with activation of the dendritic 
cells, suggesting that infected dendritic cells produced cytokines that lead to maturation (Henderson et 
al., 1997). Furthermore, Thurnher and colleagues (1997) described the effects of BCG on cultured 
human blood dendritic cells. Infection with BCG resulted in the down-modulation of endocytosis and 
the up-regulation of surface maturation markers. The maturation of infected dendritic cells was at least 
in part induced by the secretion of tumor necrosis factor-alpha (TNF-α) by these cells in response to 
BCG infection. In contrast to these findings, suggesting that dendritic cell maturation is induced by 
mycobacteria infection, other workers have reported that M. tuberculosis inhibits maturation of human 
monocyte-derived dentritic cells in vitro. Infected dendritic cells presented a minimal and reversible 
upregulation of cellular surface maturation markers and were compromised in their ability to activate 
naïve T cells (Hanekom et al., 2003). Altogether, these indicated that infection with mycobacteria 
might have diverse phenotypic effects on immature dendritic cells, in vitro.   
 
1.5. Mycobacterial manipulation of host cathepsins  
 
  Cathepsins are a larger family of proteases composed mostly by cysteine proteases, with the 
exception of cathepsins D and E which are aspartic proteases and cathepsin A and G which are 
serine proteases (Beers et al., 2003; Zavasnik-Bergant and Turk, 2006). Their classification is based 
on their structure and catalytic type (Reiser et al., 2010). In general, the cysteine cathepsins are stable 
in acidic cellular compartments as lysosomes and endosomes (Reiser et al., 2010). All cathepsins are 
synthesized as inactive proenzymes that require activaction by proteolytic cleavage (Zavasnik-Bergant 
and Turk, 2006). The major regulators of cathepsin activity are cystatins, endogenous protein 
inhibitors, which bind to the target enzyme, obstructing the active site and thereby preventing 
substrate hydrolysis (Hsing and Rudensky, 2005).  
 Cathepsins are involved in a number of important cellular processes in APCs such as 
pathogen destruction, processing of several host cell enzymes, antigen presentation and apoptosis. 
Considering antigen presentation, these proteases are implicated in the generation of mature MHC 
class II molecules and in antigen processing within endolysosomal compartments, where they 
degrade pathogens internalized by APCs into antigenic peptides presentable in MHC class II 
molecules (Baena and Porcelli, 2009; Conus and Simon, 2010; Zavasnik-Bergant and Turk, 2006).  
 Newly synthesized MHC class II αβ heterodimers assemble in the endoplasmic reticulum (ER) 
and bind to a chaperone, the invariant chain (Ii), before leaving ER towards endocytic compartments. 
The invariant chain not only function as a chaperone, assuring the proper folding and assembly of 
MHC class II molecules, but also directs trafficking of these molecules to the endosomal 
compartments, which contain the antigen peptides for loading onto MHC class II complex (Hsing and 
Rudensky, 2005; Riese et al.,1996). During the translocation through the endocytic pathway, the 
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invariant chain undergoes a stepwise proteolytic degradation (Figure 3) mediated by cathepsins that 
generate various cleavage intermediates, such as Iip22 and Iip10 intermediates. The initial cleavages 
can be executed by asparagine endopeptidase (AEP) although other proteases can perform this 
cleavage in its absence (Trombetta and Mellman, 2005). The processing of Ii culminates in the 
generation of the class II-associated invariant chain peptide (CLIP) (Beers et al., 2003; Nepal et al., 
2006). The CLIP peptide remains in the MHC class II peptide binding groove and prevents premature 
peptide loading. A second chaperone, human leukocyte antigen (HLA)-DM, will then catalyze the 
removal of CLIP, in exchange for the antigen peptides. The resulting peptide-loaded MHC class II 
complexes are then transported to the cell surface and prepared for presentation to CD4+ T-cells in 















 Macrophages and dendritic cells are equipped with a diverse group of cathepsins, most of 
which are cysteine proteases. Cathepsin B, L and S are the major cysteine proteases expressed in 
these cells and have all been suggested to participate in the processing of internalized antigens for 
CD4+T cell presentation and/or processing of invariant chain (Hsieh et al., 2002; Nepal et al., 2006). 
Cathepsin S is the principal protease involved in the late steps of li degradation in macrophages, 
dendritic cells and B cells, specifically in the conversion of Iip10 into CLIP, while in cortical thymic 
epithelial cells this process is mediated by cathepsin L (Nepal et al., 2006). Moreover, both cathepsin 
S and L have also been shown to be important in the generation of certain antigenic peptides (Hsing 
and Rudensky, 2005; Plüger et al., 2002), as well as cathepsin B (Matsunaga et al., 1993). 
 The infection with M. tuberculosis elicits a MHC class II-restricted CD4+T cell response that is 
essential to control the primary mycobacterial infection. Therefore, the integrity of the class II MHC 
Figure 2.  Invariant chain degradation events. The invariant chain (Ii chain) undergoes successive 
cleavages, during the translocation of Ii chain-MHC class II complex through the endocytic pathway of antigen 
presenting cells. This proteolytic degradation is initiated by asparagine endopeptidase (AEP) or other 
unidentified proteases, originating the li chain intermediate p10. Further cleavage (involving cathepsin S or L, 
depending on the cell types) results in the class II-associated invariant chain peptide (CLIP). Subsequently, a 
second chaperone, human leukocyte antigen (HLA)-DM, catalyzes the removal of CLIP in exchange for the 





antigen presentation pathway is necessary to ensure that the bacilli are contained and that adaptive 
immunity is established. Since, cathepsins play an important role in MHC class II antigen processing 
and presentation, pathogenic mycobacteria modulate MHC class II pathway by interfering with these 
host proteases (Nepal et al., 2006). In this context, in vitro experiments showed that M. bovis BCG 
infection causes inhibition of IFN-γ induced cathepsin S expression, in infected human acute 
monocytic leukemia cell line (THP-1) cells (Sendide et al., 2005). This was associated with an 
intracellular accumulation of MHC class II molecules complexed with cathepsin S lip10 substrate and 
with the export of immature MHC class II molecules to the cell surface. This effect was reversed by the 
addition of neutralizing antibodies that suppress IL-10, restoring the expression of active cathepsin S 
and the export of mature MHC class II molecules to the surface of infected cells. Thus, M. bovis BCG 
inhibits cathepsin S expression through the induction of the inhibitory cytokine IL-10 (Sendide et al., 
2005). In addition, the inhibition of expression or activity of other cathepsins, such as cathepsin L, in 
murine bone marrow-derived macrophages infected with either M. avium or M. tuberculosis, was also 
reported. In contrast, the cathepsin B and S activity has no obvious alteration upon mycobacterial 
infection. The inhibition of expression of this cathepsin may influence the types of T cell epitopes 
generated in antigen presenting cells (Nepal et al., 2006). 
 
1.6.  Thesis Goals 
 
 The major goal of this project is to characterize mycobacterial manipulation of host 
macrophage activation and dendritic cell maturation, in the context of host proteases such as 
lysosomal cathepsins. The study of these mycobacteria-host interactions may provide us the 
knowledge to develop new strategies for the prevention and treatment of tuberculosis. 
 In the first part of this thesis we intent to elucidate the role of mycobacteria during macrophage 
activation and dendritic cell maturation. For this purpose, human macrophages and DCs were infected 
with the avirulent M. tuberculosis H37Ra or the non-pathogenic M. smegmatis expressing green 
fluorescent protein (GFP) and their surface phenotype was analyzed using flow cytometry. We 
focused our analysis in the expression of surface activation or maturation markers, involved in antigen 
presentation and T cell stimulation. We also studied the influence that these mycobacteria species had 
on macrophage activation and DCs maturation, previously induced by IFN-γ and TNF-α, respectively.  
 The second part of this thesis, addresses the role of lysosomal cathepsins during 
mycobacteria infection of host macrophages and DCs. First, we evaluated whether mycobacteria 
infection modulates lysosomal cathepsins expression, by analyzing their protein levels in human 
macrophages and dendritic cells infected with the virulent M. tuberculosis H37Rv or the non-
pathogenic M. smegmatis. Second, we investigated the importance of these cathepsins on M. 
tuberculosis intracellular survival within macrophages, by silencing cathepsins expression in THP-1 
cells, using a shRNA lentiviral library, followed by infection with M. tuberculosis H37Rv or M. 
tuberculosis H37Ra strain and consequent quantification of intracellular survival through colony 
forming units counting. 
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2. Materials and Methods 
 
2.1. Role of mycobacteria during macrophage activation and DC maturation 
 
2.1.1. Bacterial cultures and growth conditions 
 
 M. tuberculosis H37Ra (25177, ATCC) expressing green fluorescent protein (GFP) (M. 
tuberculosis H37Ra GFP) was generated by electroporation with pMN437 plasmid (Addgene plasmid 
# 32362), which harbors a gene that encodes GFP protein (mycgfp2+) and an hygromycin resistance 
gene for selection (a kind gift from Michael Niederweis). This green fluorescent protein (GFP)-
expressing strain was cultivated in complete growth medium containing Middlebrook’s 7H9 broth 
(Difco) supplemented with 0.2% (v/v) glycerol (Sigma), 10% (v/v) OADC (BD- Becton, Dickinson and 
Company) and 0.05% (v/v) Tyloxapol (Sigma). The medium was also supplemented with 50μg/ml of 
hygromycin (Invitrogen) to maintain the selective pressure.  
 M. smegmatis mc2155 (700084, ATCC) harbouring a p19-(long-lived) EGFP plasmid (M. 
smegmatis GFP) was grown in medium containing Middlebrook’s 7H9 broth (Difco) and Nutrient broth 
(Difco), supplemented with 0.5% glucose, 0.05% (v/v) Tyloxapol (Sigma) but also with 50μg/ml of 
hygromycin (Invitrogen) in order to stabilize GFP expression (Anes et al., 2006). Both cultures were 
incubated at 37°C with 100 rpm agitation.  
   Prior to infection, in order to obtain a single cell suspension, all mycobacterial cultures were 
centrifuged at 3000 x g for 10 minutes, washed with PBS (Phosphate buffer saline) and centrifuged a 
second time in the same conditions. Then, the bacterial pellet was resuspended in the desired cell 
culture medium without antibiotics. To remove the clumps, the mycobacterial suspension was passed 
through a 21G needle and then sonicated for 5 minutes. Residual aggregates were eliminated by a 
low speed centrifugation (350 x g) for 1 minute. Single cell suspension was verified by light 
microscopy. Finally, optical density at 600 nm (OD600nm) was used to determine cellular density in the 




 Construction of Mycobacterium tuberculosis H37Ra GFP 
 
o pMN437 plasmid purification – Transformation of E. coli with pMN437 plasmid 
 
The chemically competent E. coli strain was placed on ice, in contact for 10 minutes with 100 
ng of pMN437 DNA. The mixture was then incubated at 45 ºC for 45 seconds (heat-shock 
transformation), followed by another 10 minutes on ice. The bacteria cells were inoculated into SOC 
medium (Super Optical Broth; Sigma) and incubated at 37 ºC, under agitation for 1 hour. Following 
this, the cultures were plated in Luria-Bertani (LB) agar medium (Sigma) containing hygromycin and 
were incubated at 37 °C overnight (Hanahan and Harbor, 1983). As a confirmation of E. coli 
transformation with the pMN437 plasmid, colonies with GFP fluorescence were observed by 
fluorescence microscopy. The selected transformants were grown in LB broth with 50 µg/ml 
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hygromycin at 37 °C, under agitation, overnight. The pMN437 plasmid was purified using a PuroLink® 
Quick Plasmid Miniprep Kit (Invitrogen), according to the manufacturer’s instructions, and was 
quantified using NanoDrop ND 100 (ThermoCientific).   
 
o Electroporation of M. tuberculosis H37Ra with pMN437 plasmid 
  
 To prepare electrocompetent mycobacteria cells, M. tuberculosis H37Ra cultured as described 
above, was incubated on ice for 90 minutes and then centrifuged at 3000 x g for 10 minutes. Following 
this, mycobacteria cells were washed three times in ice-cold 10 % glycerol and before storage at            
-80 ºC, bacterial cells were also resuspended in ice-cold 10 % glycerol.  
The pMN437 plasmid (2 µg DNA) was electroporated into electrocompetent M. tuberculosis 
H37Ra, applying one single pulse of 1.8 kV, 25 µF, with the pulse-controller resistance set at 200 Ω 
resistance, in 0.2 cm cuvettes. Electroporated mycobacteria were incubated in Middlebrook’s 7H9 
broth (described above) at 37 ºC for 36 hours, to allow the expression of the antibiotic-resistant gene 
carried on the pMN437 plasmid. Subsequently, mycobacteria cells were plated on Middlebrook 7H10 
agar medium (Difco) supplemented with 10 % (v/v) OADC (BD), 0.5 % (v/v) glycerol (Sigma) and 50 
μg/ml of hygromycin, and incubated at 37 ºC. After 4 weeks, transformant colonies were isolated and 
then inoculated in the Middlebrook’s 7H9 broth (described above) with 50 μg/ml of hygromycin. 
Adapted from (Goude and Parish, 2008). 
 
2.1.2. Peripheral Blood Mononuclear Cells: Isolation Procedure 
 
 Peripheral Blood Mononuclear Cells (PBMCs) were obtained from buffy coat preparations 
kindly provided by Instituto Português do Sangue. The mononuclear cells were isolated by density 




(GE Healthcare). Briefly, the buffy coat was diluted 
(1:1) in MACS Buffer, which was prepared by diluting MACS BSA (bovine serum albumin) Stock 
Solution 1:20 with autoMACS
TM
 Rinsing Solution (both purchased from MACS, Miltenyi Biotec).  Then, 




(GE Healthcare) and an 800 x g 
centrifugation for 20 minutes at room temperature was performed without brakes and with minimal 
acceleration. The resulting interface, which contains the PBMCs, was collected and washed two times 
with cold MACS Buffer, through a 450 x g centrifugation for 10 minutes at 4 ºC, followed by a second 
centrifugation at 350 x g for 5 minutes at 4º C. Subsequently, monocytes were positively selected from 
total PBMCs, using anti-CD14-labeled magnetic beads and MACS separation LS columns (MACS, 
Miltenyi Biotec), according to the manufacturer’s instructions. Depending on the following experiments, 
monocytes were plated at a desired density in the appropriate plates, in order to differentiate into 







2.1.3. Human macrophage and dendritic cell differentiation 
 
 For macrophages differentiation, CD14 monocytes were resuspended in RPMI-1640 medium 
with GlutaMAX
TM 
(Gibco) supplemented with 1 % HEPES (Gibco) at pH 7.4 and were allowed to 
attach to the plate for 2 hours at 37 ºC. Following this, cells were cultured with RPMI-1640 medium 
with GlutaMAX
TM 
(Gibco) supplemented with 10 % (v/v) Heat-Inactivated Fetal Bovine Serum (iFBS) 
(Invitrogen), 1 % HEPES (Gibco) at pH 7.4, 1 % (v/v) sodium pyruvate (Gibco), 1 % (v/v) Penicillin-
Streptomycin (Gibco), 0.1 % 2-Mercaptoethanol (Gibco) and 20 ng/ml M-CSF (macrophage-colony-
stimulating factor) (Immunotools), for 7 days at 37 ºC in 5 % CO2 atmosphere. On day 4, fresh 
medium with a full dose of M-CSF was added to the culture. 
 For dendritic cells differentiation, monocytes were resuspended in RPMI-1640 medium with 
GlutaMAX
TM 
(Gibco) containing 10 % (v/v) iFBS (Invitrogen), 1 % HEPES (Gibco) at pH 7.4, 1 % (v/v) 
sodium pyruvate (Gibco), 1 % (v/v) Penicillin-Streptomycin (Gibco), 0.1 % 2-Mercaptoethanol (Gibco), 
20 ng/ml IL-4 (Immunotools) and 10 ng/ml GM-CSF (granulocyte-macrophage colony-stimulating 
factor) (Immunotools), for 7 days at 37 ºC in 5 % CO2
 
atmosphere. On day 2 and 4, new medium with 
a full dose of IL-4 and GM-CSF was added to the culture.  
 To analyze cell surface markers expression of human monocyte-derived macrophages and 
dendritic cells, monocytes were plated in 12-well plates, at a density of 1x10
6
 cells per well. 
  
2.1.4. Treatment with IFN-γ and TNF-α 
  
 When required, human monocyte-derived macrophages were stimulated with human IFN-γ 
(Immunotools) at 100 UI/ml and human monocytes-derived dendritic cells were stimulated with TNF-α 
(Immunotools) at 50 ng/ml, overnight, and prior to infection. 
 
2.1.5. Mycobacteria infection of human macrophages and dendritic cells 
 
 For analysis of cell surface markers expression of mycobacteria infected human monocyte-
derived macrophages and dendritic cells, monocytes were plated in 24-well plates, at a density of 
5x10
5
 cells per well and following 7 days of differentiation, human macrophages and dendritic cells 
were stimulated as described above or were left unstimulated. Then, these cells were infected with 
single-cell suspensions of M. smegmatis GFP or M. tuberculosis H37Ra GFP (prepared as described 
above), at a multiplicity of infection (MOI) of 1 and were incubated with the macrophage or dendritic 
cell differentiation medium without antibiotics (infection medium), for 3 hours at 37 °C, to allow the 
uptake of mycobacteria. After 3 hours infection, in order to remove non-internalized extracellular 
mycobacteria, cells were washed with infection medium and cultivated for an additional 24 hours in 
infection medium supplemented with 10 μg/ml of gentamicin (Gibco). One day after infection, cells 
were analyzed by flow cytometry. Uninfected human macrophages and dendritic cells, non-stimulated 





2.1.6. Cell surface staining and flow cytometry 
 
 Uninfected or infected human macrophages and dendritic cells were washed with PBS, 
harvested by incubation with 5 mM EDTA (Ethylenediaminetetraacetic acid) (Gibco) in PBS for 10 
minutes, followed by fixation with 4 % paraformaldehyde. Subsequently, cells were washed with 
MACS buffer (MACS, Miltenyi Biotec) and incubated for 30 minutes at room temperature with the 
appropriate fluorochrome-conjugated antibodies (Table 1). Cells were washed twice before cell 
surface markers expression was assessed, using Guava easyCyte
TM
 HT flow cytometer (Millipore). 
Data analysis was performed using Guava InCyte software (Millipore) and results were expressed as 
the Mean Fluorescence Intensity (MFI) of each surface marker, percentage of positive cells for each 
surface marker or as the percentage of GFP-positive cells. A total of 5,000 events per sample were 
analyzed. Only viable cells were considered in the analysis.  
 
2.2. Role of host cathepsins during mycobacteria infection in human 
macrophages and dendritic cells 
 
2.2.1. Mycobacterial manipulation of cathepsins in human macrophages and DCs 
  
2.2.1.1. Bacterial cultures and growth conditions 
 
 M. smegmatis was grown as described above but without hygromycin addition. M. tuberculosis 
H37Rv (25618, ATCC), was cultivated in complete growth medium containing Middlebrook’s 7H9 broth 
(Difco) supplemented with 0.2 % (v/v) glycerol (Sigma), 10 % (v/v) OADC (BD- Becton, Dickinson and 
Company) and 0.05 % (v/v) Tyloxapol (Sigma) and were incubated at 37 ºC with 100 r.p.m agitation. 
Before any experiment, the individualization of mycobacterial culture was performed as previously 
described. 
 
2.2.1.2. Mycobacteria infection of human macrophages and dendritic cells 
 
 CD14 monocytes isolated from the peripheral blood (as described above) were seeded at a 
density of 2x10
6 
cells per well, in a 6-well plate and differentiated into human macrophages and 
dendritic cells with the appropriate cytokines, for 7 days, as described above. The human monocyte-
derived macrophages and dendritic cells (non-stimulated and stimulated) were infected with single-cell 
suspensions of M. smegmatis or M. tuberculosis H37Rv at a MOI of 1 for 3 hours. Following 3 hours 
infection, cells were washed and cultivated for an additional day, in infection medium supplemented 
with 10 μg/ml of gentamicin to destroy extracellular bacteria. To analyze the cathepsins expression, 






2.2.1.3. Western Blot  
  
 The adherent cells were scraped with Laemmli buffer 2x (Sigma) diluted in PBS (1:2) and the 
cells in suspension were centrifuged and ressuspended with the same buffer. The resulting cell 
lysates were denatured at 95 ºC for 5 minutes. The same volume of protein extracts were loaded on a 
12 % SDS-PAGE gel (Sodium Dodecyl Sulfate PolyAcrylamide Gel Electrophoresis) and the protein 
separation was performed by electrophoresis at 200 V for 1 hour. Then proteins were transferred to a 
nitrocellulose membrane (0.45 µm pore size; Bio-Rad) at 30 V, 4 ºC, overnight, in a wet transfer 
system, Mini Trans-Blot® module (Bio-Rad). The membrane was blocked for 1 hour in Blocking Buffer, 
prepared with 5 % Bovine Serum Albumin (BSA; Merck) in TBS-T (Tris-buffered saline 1x, 0.1 % 
Tween20), and then incubated for 2 hours at room temperature with the appropriate primary 
antibodies (Table 2(a)) diluted in TBS-T with 1 % BSA (Merck). After washing the nitrocellulose 
membrane with TBS-T, incubation with the appropriate horseradish peroxidase-conjugated secondary 
antibody (Table 2(b)) diluted in TBS-T with 5 % BSA (Merck) was performed, for 1 hour at room 
temperature. The membrane was washed again, before enhanced chemiluminescence detection. 
Cathepsin bands were visualized using ECL Prime Western Blotting Detection Reagents (Amersham). 
Quantification of blot bands was performed using ImageJ 1.45 software (National Institutes of Health, 
USA). Anti-tubulin antibody was used as a normalization control. 
 
2.2.2. The effect of host cathepsins on mycobacteria intracellular survival  
 
2.2.2.1. Bacterial cultures and growth conditions 
 
 M. tuberculosis H37Ra and M. tuberculosis H37Rv were cultivated as described above but 
without hygromycin addition. Before any experiment, the individualization of mycobacterial culture was 
performed as previously described. 
 
2.2.2.2. THP-1 cell line and growth conditions 
 
 Human acute monocytic leukemia cell line, THP-1 (TIB-202™, ATCC), was grown in RPMI-
1640 medium with GlutaMAX
TM 
(Gibco) supplemented with 10 % (v/v) iFBS (Invitrogen), 1 % (v/v) L-
glutamine (Gibco), 1 % (v/v) HEPES (Gibco) at pH 7.4, 1 % (v/v) sodium pyruvate (Gibco), 1 % (v/v) 
MEM-non essential amino acids (Gibco) and 1 % (v/v) Penicillin-Streptomycin (Gibco), and incubated 
at 37 °C in 5 % CO2 atmosphere. 
 
2.2.2.3. HEK 293T cell line and growth conditions 
 
 Human embryonic kidney 293T cell line, HEK 293T (CRL-11268™, ATCC), was maintained in 
Dulbecco’s Modified Eagle Medium (DMEM) (Gibco) supplemented with 10 % (v/v) iFBS (Invitrogen) 
and 1 % (v/v) Penicillin-Streptomycin (Gibco) and incubated at 37 °C in 5 % CO2 atmosphere. 
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2.2.2.4. Stable knockdown of cathepsin genes in THP-1 cells using lentiviral vectors 
 
 To knockdown cathepsin gene expression in THP-1 cell line, we used a replication-
incompetent lentiviral vector that infects the target cells, integrates into its genome, endogenously 
expressing short hairpin RNAs (shRNAs). The expressed shRNAs were subsequently processed by 
the RNA interference machinery of the cell, into small interfering RNAs (siRNAs), which will target the 
degradation of cathepsins mRNA (Sliva and Schnierle, 2010; Stewart et al., 2003). Lentiviral particles 
were produced by co-transfecting a packing cell line with a three-plasmid expression system: a 2
nd 
generation packaging plasmid pCMV-dR8.91 expressing viral enzymes and structural proteins, 
needed for infectious particle formation, an envelope plasmid pCMV-VSVG (Addgene plasmid #8454) 
containing the envelope glycoprotein of vesicular stomatitis virus (VSV-G), and the lentiviral vector, 
pLKO.1 puro plasmid (Addgene plasmid #8453) that expresses the shRNA and carries a puromycin 
resistance marker, for selection of the cells that stably express the shRNA of interest. Therefore, this 
method allows a long-term silencing of cathepsin genes within THP-1 cell line (Moffat et al., 2006; 
Pluta and Kacprzak, 2009). 
 Purification of shRNA-pLKO.1 plasmid, lentiviral production and lentiviral infection were 
performed according to TRC lentiviral protocols present at the RNAi Consortium website 
(https://www.broadinstitute.org/genome_bio/trc/publicProtocols.html). 
 
o Purification of cathepsin shRNA-pLKO.1 Plasmid 
 
 The cathepsins shRNA-pLKO.1 vectors were kindly provided as bacterial glycerol stocks by 
Prof. Luís Moita (Instituto de Medicina Molecular, Lisbon). In order to isolate shRNA-pLKO.1 plasmid, 
the E. coli transformants were grown in TB (terrific broth) medium containing 100 µg/ml carbenicillin 
(Sigma Aldrich®) for 16 hours at 37 ºC, 300 r.p.m agitation. Following 16 hours of incubation, the DNA 
plasmid was purified using a PuroLink® Quick Plasmid Miniprep Kit (Invitrogen), according to the 
manufacturer’s instructions, and was quantified using NanoDrop ND 100.   
 
o Lentiviral production in HEK 293T cell line 
 
 HEK 293T packaging cells were seeded at a density of 2,2x10
4
 cells per well in DMEM 
medium (Gibco) supplemented with 10 % (v/v) iFBS without Penicillin-Streptomycin (Gibco), in flat-
bottom 96-well microplates. After 24 hours of incubation at 37 ºC in 5 % CO2 atmosphere, packaging 
cells with ~ 70% confluence were co-transfected with 100 ng of the packaging plasmid pCMV-dR8.91, 
10 ng of the envelope plasmid pCMV-VSV-G and the 100 ng of the shRNA-pLKO.1 puro plasmid, 
using FuGENE 6 transfection reagent (Roche) in Opti-MEM medium (Invitrogen). Following 18 hours 
of incubation at 37 ºC in 5 % CO2 atmosphere, the medium containing the transfection reagent was 
replaced by DMEM medium supplemented with 30 % iFBS (Invitrogen) and 1 % Penicillin-




o Lentiviral Infection of THP-1 cell line 
  
 Following production of shRNA lentivirus, transduction of THP-1 cell line was performed in 
order to knockdown cathepsin genes. THP-1 cells were seeded at a density of 5x10
4 
cells per well in 
round bottom 96-well microplates. Cells were centrifuged and resuspended in 10 µl of lentivirus and 
40 µl of fresh THP-1 culture medium containing 8 µg/ml of Polybrene B (Sigma Aldrich®) was added 
to each well. Microplates were spun at 900 x g for 90 minutes at 37 ºC (spinoculation). Following 
spinoculation, supernatants were replaced with fresh THP-1 culture medium and cells were incubated 
at 37 ºC in 5 % CO2 atmosphere. After 48 hours, transduced cell selection was performed by replacing 
medium in each well with fresh THP-1 culture medium supplemented with 5 µg/ml of puromycin 
(Sigma). Cells were maintained under puromycin selection for 3 days and then each microplate was 
split into two replica plates and incubated at 37 ºC in 5 % CO2 atmosphere, in order to expand 
transduced cells. The incubation period following split, was dependent on the subsequent assays 
performed. Previous to each assay, cells were collected and their number normalized. 
   
o Validation of cathepsin genes knockdown by western blotting 
  
 Each cathepsin gene has five different shRNAs with different knockdown efficiencies. In order 
to access the level of knockdown of each cathepsin shRNAs, relative quantification of cathepsin genes 
expression was performed at protein level by western blotting. 
 THP-1 transduced cells were seeded in 6-well plate, at a density of 2x10
6
 cells per well. In 
order to induce differentiation of THP-1 monocytes into macrophages, cells were incubated in THP-1 
culture medium supplemented with 20 nM phorbol 12-myristate 13-acetate (PMA) (Sigma) for 24 
hours. Then, the THP-1 culture medium supplemented with PMA was replaced with new fresh PMA-
free medium. Following 24 hours, in order to quantify at cathepsin protein expression, the cells were 
lysed, proteins collected and a western blot was performed, as previously described. The primary and 
secondary antibodies used in western blot were listed in Table 2 (a)(b).  
  
2.2.2.5. Quantification of mycobacteria intracellular survival in silenced macrophages 
 
 Before infection, silenced THP-1 cells were seeded at a density of 7.5 x 10
4
 cells per well in 
flat-bottom 96-well microplate, in THP-1 culture medium supplemented with PMA in order to 
differentiate into macrophages (as previously described). These cells were infected with single-cell 
suspensions of M. tuberculosis H37Ra and M. tuberculosis H37Rv at a MOI of 1 according with the 
previous protocol. After 3 hours infection, cells were washed three times with THP-1 culture medium 
without antibiotics and cultivated with 10 μg/ml of gentamicin for 24 hours. Culture medium was 
changed every two days during the course of the experiment. 
 To quantify mycobacteria intracellular survival, at day 5 post-infection cells were washed and 
lysed with 0.5 % Igepal (Sigma Aldrich®) solution in distilled water. Serial dilutions of the lysate were 
performed in distilled water before being plated on Middlebrook 7H10 agar medium (Difco) 
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supplemented with 10 % (v/v) OADC (BD) and 0.5 % (v/v) glycerol (Sigma). Colony forming units 
(CFU) were counted after 3 weeks of incubation at 37 °C. 
 
2.2.2.6. Statistical analysis 
  
 Statistical treatment was performed using SigmaPlot 11.0. The analysis was made using One 
Way ANOVA followed by multiple comparisons versus a control group using Holm-Sidak test. The 
differences were considered statistically significant when p<0,05. The results are represented as the 
mean ± Standard deviation (SD). 
 
2.3. Antibodies used to perform Flow Cytometry and Western Blot 
 
  Table 1: List of antibodies used to perform Flow Cytometry Assays 
Fluorochrome-conjugated antibodies Company 
PE-Mouse anti-human CD1a BD PharmingenTM 
Alexa Fluor® 488- anti-human CD14 Biolegend 
PE-Mouse anti-human CD86 BD PharmingenTM 
Alexa Fluor® 488- anti-human CD206(MMR) Biolegend 
PE-anti-human CD209 (DC-SIGN) Biolegend 
PerCP-anti-human HLA-DR Biolegend 
 




Mouse monoclonal anti-human cathepsin B
 
1:2000 Abcam® 
Rabbit polyclonal anti-human cathepsin S 1:4000 Abcam® 
Rabbit polyclonal anti-human β-tubulin 1:5000 Abcam® 
Secondary Antibodies 
(b) Dilution Company 
Anti-mouse IgG (H+L)-HRP conjugated  1:2000 Bio-Rad 




3. Results  
 
3.1. Role of mycobacteria during macrophage activation and DC maturation         
 
 In the first part of this project, we investigated the role of mycobacteria during macrophage 
activation and dendritic cell maturation. Initially, human peripheral blood monocytes were isolated from 
healthy human donors, differentiated towards human macrophages or human dendritic cells and their 
morphology and surface phenotype were characterized. Subsequently, we infected the human 
peripheral blood monocyte-derived macrophages and monocyte-derived dendritic cells with the M. 
tuberculosis H37Ra or M. smegmatis and examined surface expression of activation and maturation 
markers in these infected cells, using flow cytometry. We analyzed the outcomes of infection with both 
strains in these cell types and compared them to the effects of a positive control for macrophage 
activation and dendritic cell maturation. We also studied the outcomes of infection with these 
mycobacteria, in IFN-γ-induced macrophage activation and TNF-α-induced dendritic cell maturation.
 To perform these experiments, we used green fluorescent protein (GFP)-expressing 
mycobacteria. We infected human macrophages and dendritic cells with M. tuberculosis H37Ra GFP 
or M. smegmatis GFP and selected the infected host cells (GFP-positive cells) by flow cytometry. 
Using GFP-expressing mycobacteria enabled us to discriminate between mycobacteria infected and 
uninfected cells within the same well, which was fundamental since infection could be heterogeneous 
and the fraction of cells that remained uninfected (bystander cells) could have interfered in the 
interpretation of the results. Therefore, we guaranteed that the observed effects were simply from 
macrophages and dendritic cells that have internalized M. tuberculosis H37Ra GFP or M. smegmatis 
GFP.  
 
3.1.1.  Characterization of resting macrophages and immature dendritic cells  
 
 Macrophages were differentiated from CD14 peripheral blood monocytes cultured in presence 
of M-CSF for 7 days, as described above. It was evident from our observations, using optical 
microscopy, that human monocytes cultured in these conditions, acquired features of resting 
macrophages (M0). Some cells presented an elongated morphology but most of them remained with a 
round morphology after differentiation. They also exhibited an increase in size and adherence in 
comparison with human monocytes (results not shown). Moreover, surface phenotypic analysis, using 
flow cytometry, (Figure 3) also revealed that these cells expressed a macrophage-like phenotype. The 
cells expressed high levels of CD14, a surface marker for macrophages, and lacked expression of 
CD1a, which indicates together with the absence of DC-SIGN (Dendritic Cell-Specific Intercellular 
adhesion molecule-3-Grabbing Non-integrin), that these cells didn’t differentiate into DCs. 
Furthermore, they exhibited moderate levels of HLA-DR molecules and co-stimulatory molecules 
CD86. The cell surface expression of mannose receptor (CD206), which is a surface marker involved 
in the receptor-mediated uptake (Ernst, 1998), was also analyzed. As expected, these cells expressed 
intermediated levels of both surface markers. These results, together with the cellular morphology, 
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suggested that these cells acquired the morphologic and phenotypic characteristics of resting 
macrophages (Sallusto et al., 1995; Smith et al., 1998; Young et al., 1990).  
 Dendritic cells were generated from human peripheral blood monocytes cultured in the 
presence of GM-CSF and IL-4, as previously described. After 7 days of incubation, examination of the 
culture using optical microscopy revealed that cells attained the characteristic morphology of immature 
DC (imDCs), which included round cells with small cytoplasmic projections and tendency to aggregate, 
forming numerous floating clusters (results not shown).  Analysis by flow cytometry of the cell surface 
markers (Figure 3) showed that DCs expressed high levels of CD1a but low levels of CD14 compared 
to resting macrophages. In addition, these cells constitutively express high levels of MHC class II 
molecules, and relatively moderate levels of the co-stimulatory molecules CD86. These cells also 
expressed elevated levels of mannose receptor and DC-SIGN, two important receptors present on 
imDCs for the efficient capture of a variety of antigens, including viable mycobacteria (Geijtenbeek et 
al., 2003). These results were in agreement with previous studies performed, that described the 
morphology and surface phenotype of imDCs, obtained using GM-CSF and IL-4 (Markowicz and 
Engleman, 1990; Sallusto et al., 1995). This suggests that these cells generated in our experiment 
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Figure 3. Analysis of surface markers expression of human monocyte-derived macrophages and human 
monocyte-derived dendritic cells. CD14 monocytes were isolated from the peripheral blood as described in 
Materials and Methods and were cultured for 7 days, in the presence of M-CSF to develop into macrophages or 
in the presence of GM-CSF and IL-4 to generate DCs. Cells were then stained with specific antibodies (Abs) for 
the surface markers indicated and their surface phenotype was assessed by flow cytometry. A total of 5,000 
events per sample were analyzed. Results are expressed as mean fluorescence intensities (MFI) from one 




3.1.2. Role of mycobacteria during macrophage activation 
 
 To investigate the influence of mycobacteria infection in macrophage activation, we initiated 
our study with the development of a positive control for classical macrophage activation (M1). In 
general, M1 macrophages are obtained by exposure of resting macrophages (M0) to two inflammatory 
stimuli, IFN-γ and LPS (Mosser, 2003). In preliminary experiments, we stimulated M0 with both 
cytokines and observed that IFN-γ induced a stronger up-regulation of the proinflammatory M1 
phenotype, at the level of antigen presenting molecules, than LPS (data not shown). As a result, IFN-γ 
was selected to stimulate M0 macrophages. 
 M0 and M1 macrophages were then infected with M. tuberculosis H37Ra GFP or M. 
smegmatis GFP and the number of GFP-positive cells was assessed by flow cytometry. The 
percentages of infected cells for each infection were determined (Figure 4): in M1 macrophages, the 
percentage of either M. smegmatis GFP or M. tuberculosis H37Ra GFP infected cells were lower than 
that observed in M0 macrophages. This may be attributed to the higher bactericidal activity of M1 
activated macrophages in comparison with resting macrophages. The percentage of M. smegmatis 
GFP and M. tuberculosis H37Ra GFP infected cells was similar when M0 macrophages were used as 
host, whereas in M1 activated macrophages the percentage of M. smegmatis GFP infection was lower 
than the percentage of M. tuberculosis H37Ra GFP. This is probably a result of the higher bactericidal 
activity of M1 macrophages, in combination with the fact that the non-pathogenic mycobacteria M. 
smegmatis may be rapidly destroyed in the M1 environment, in contrast to M. tuberculosis H37Ra that 
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Figure 4. M. tuberculosis H37Ra GFP and M. smegmatis GFP infection of resting human monocyte-
derived macrophages and IFN-γ-activated human monocyte-derived macrophages. CD14 monocytes were 
isolated from peripheral blood as described in Material and Methods and were cultured for 7 days in medium 
containing M-CSF, to obtain resting macrophages (M0). These cells were stimulated for further 24 hours with 
IFN-γ to generate M1 activated macrophages. M0 and M1 were infected with M. tuberculosis H37Ra GFP 
(H37Ra) or M. smegmatis GFP (M. smeg) at MOI 1 and 24 hours post-infection, cells were fixed and their GFP 
fluorescent intensity was measured by flow cytometry. (A) The results, obtained from 5,000 living cells, are 
expressed as the percentage of GFP-positive cells, which represent the percentage of cells infected with 
fluorescent mycobacteria. (B) Representative flow cytometry histograms show the GFP expression from resting 
macrophages (M0) and IFN-γ-activated macrophages (M1) infected with M. tuberculosis H37Ra or M. smegmatis 
GFP.    
 












 Next, the surface phenotype of M0 infected macrophages with M. tuberculosis H37Ra GFP or 
M. smegmatis GFP at MOI 1, for 24 hours, was analyzed by flow cytometry (Figure 5). Since, HLA-DR 
and CD86 represent key molecules involved in antigen presentation and T cell stimulation, the cell 
surface expression of these 
markers was examined in 
infected macrophages and 
compared to that on both 
uninfected M0 and M1 polarized 





























































Figure 5. Effect of mycobacteria infection during activation of human monocyte-derived macrophages. 
Resting macrophages (M0) differentiated as described in Materials and Methods were infected with M. tuberculosis 
H37Ra GFP or M. smegmatis GFP at MOI 1 or were left uninfected. IFN-γ-stimulated macrophages (M1) were used 
as a macrophage activation control. Cells were then fixed and stained with specific Abs for the surface markers 
indicated, 24 hours after infection. Activation was determined by measuring through flow cytometry the cell surface 
expression of the costimulatory and antigen-presenting molecules, CD86 and HLA-DR, respectively. (A) Results are 
expressed as the mean fluorescence intensities (MFI) for each surface marker (shown on the right). (B) 
Representative flow cytometry histograms show the HLA-DR and CD86 expression from resting macrophages (M0), 
IFN-γ-activated macrophages (M1), M0 infected with M. tuberculosis H37Ra (H37Ra) and M0 infected M.  













           HLA-DR      CD86 
22 
 
 As expected, IFN-γ-activated M1 macrophages showed up-regulation of HLA-DR and CD86 
molecules, in comparison with the M0 phenotype. Infection of M0 macrophages with M. smegmatis 
GFP also induced further up-regulation of HLA-DR and CD86 molecules, evidenced by an increase in 
the percentage of positive cells and in the expression of both surface markers. In contrast to M. 
smegmatis GFP, the avirulent M. tuberculosis H37Ra GFP neither enhanced nor inhibited surface 
expression of CD86 and slightly down-regulated HLA-DR expression (~6% decrease)(Figure 5A and 
5B). This lead us to speculate that the exposure of resting macrophages to avirulent M. tuberculosis 
H37Ra appears to prevent the induction of M1 pro-inflammatory phenotype at the level of the antigen-
presenting molecules, while the non-pathogenic M. smegmatis induce this M1 pro-inflammatory 
phenotype, almost as effective as IFN-γ treatment. 
In agreement with the previous results, we raised the question whether M. tuberculosis H37Ra 
and M. smegmatis would interfere with macrophage activation induced by the pro-inflammatory stimuli, 
IFN-γ. Therefore, M0 macrophages activated by treatment with IFN-γ were infected with M. 
tuberculosis H37Ra GFP or M. smegmatis GFP at MOI 1. The surface expression of HLA-DR and the 
co-stimulatory molecules CD86 of infected and uninfected M1 (used as the control) was examined by 
flow cytometry, 24 hours post-infection. As shown in Figure 6, M. tuberculosis H37Ra GFP infected 
M1 macrophages displayed a slightly increase in surface expression of HLA-DR and CD86. When M1 
cells were infected with M. smegmatis GFP, HLA-DR expression was slightly enhanced and the 
expression of CD86 in these cells did not change relative to the control. These results indicate that M. 
tuberculosis H37Ra did not impair IFN-γ-induced activation, at least at the level of antigen-presenting 
molecules, which might suggests that IFN-γ-induced activation was able to overcome the mechanisms 
of inhibition employed by these mycobacteria, observed in our previous results (Figure 5). M. 
smegmatis infected M1 cells present a similar phenotype to that of the control, which it was not 
surprising, since exposure of M0 macrophages to these environmental mycobacteria also induced a 
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Figure 6. Effect of mycobacteria infection on macrophage activation phenotype induced by IFN-γ. 
Resting macrophages (M0) generated as described in Materials and Methods were stimulated with IFN-γ for 
additional 24 hours, in order to activate these cells. IFN-γ- activated macrophages (M1) were either infected with 
M. tuberculosis H37Ra GFP (H37Ra) or M. smegmatis GFP (M. smeg) at MOI 1 or were left uninfected, as a 
macrophage activation control. Cells were then fixed, stained with the respective Abs and the cell surface 
expression of CD86 and HLA-DR was assessed by flow cytometry, 24 hours post-infection. Data are expressed 




3.1.3. Role of mycobacteria during dendritic cell maturation 
 
To decipher the role of mycobacteria infection during DC maturation process, a positive 
control for DC maturation was required. To accomplish this, imDCs were stimulated with TNF-α, for an 
additional day, in order to obtain mature DCs (mDCs). We exposed these cells to TNF- α, since the 
role of this cytokine, in the induction of DC maturation in vitro is well documented (Roake et al., 1995; 
Sallusto and Lanzavecchia, 1994).  
 imDCs and mDCs were then infected with M. tuberculosis H37Ra GFP or M. smegmatis GFP 
and the number of GFP-positive cells was quantified by flow cytometry. Figure 7 displays the 
percentages of infected cells for each infection, as well as the phagocytic capacity of DCs generated in 
these experiments. One day after infection, the percentage of M. tuberculosis H37Ra GFP infected 
cells were slightly higher than the percentage of M. smegmatis GFP infected cells. Furthermore, a 
clear difference in the percentage of infected cells was observed, when comparing imDCs and mDCs 
(Figure 7A and 7B), which was 3.7-fold higher in imDCs relatively to mDCs in M. smegmatis GFP 
infection and 3-fold higher in imDCs compared with mDCs in M. tuberculosis H37Ra GFP infection. 
The fact that the number of infected cells in the mDCs population was lower than in imDCs confirms 
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Figure 7. M. tuberculosis H37Ra GFP and M. smegmatis GFP infection of immature human monocyte-
derived DCs and mature human monocyte-derived DCs.  CD14 monocytes were isolated from peripheral 
blood and were cultured for 7 days with GM-CSF and IL-4 to develop into immature dendritic cells (imDCs). 
These cells were then cultured in the presence of GM-CSF and IL-4 either with or without TNF-α, to generate 
mature DCs (mDCs) or to maintain the immature phenotype. imDCs and mDCs were infected with M. 
tuberculosis H37Ra GFP (H37Ra) or M. smegmatis GFP (M. smeg) at MOI 1. Cells were then fixed and their 
GFP expression levels were measured using flow cytometry, 24 hours post-infection. (A) The results obtained 
from 5,000 living cells are presented as the percentage of DCs expressing GFP (B) Representative flow 
cytometry histograms show the GFP expression from imDCs and mDCs, infected with M. tuberculosis H37Ra 
GFP or M. smegmatis GFP. 
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 Then, the surface phenotype of infected imDCs with M. tuberculosis H37Ra GFP or M. 
smegmatis GFP at MOI 1, 24 hours post-infection, was examined by flow cytometry (Figure 8A and 
8B). We focused our attention on surface maturation markers involved in antigen presentation and T 
cell interaction, such as CD1a, CD86 and HLA-DR. Infected imDCs phenotype was compared with 
that from both uninfected imDCs and mDCs. As shown in Figure 8, TNF-α-stimulation of imDCs 
resulted in a strong increase of HLA-DR and CD86 expression (~2-fold increase and 3-fold increase, 
respectively), but in a slightly down-regulation of CD1a molecules. An increase in HLA-DR and CD86 
expression was also observed after infection of imDCs with both M. tuberculosis H37Ra GFP and M. 
smegmatis GFP. However, M. tuberculosis H37Ra induced somewhat higher up-regulation of HLA-DR 
and CD86 molecules than M. smegmatis, which indicates that both strains induce maturation of DCs, 
but the extent of induction by M. tuberculosis H37Ra is rather higher than by M. smegmatis. Relatively 
to the expression of CD1a, although TNF-α-stimulation of imDC resulted in a decrease in this surface 
marker expression, both M. tuberculosis H37Ra GFP and M. smegmatis GFP infection induced a 
similar up-regulation of this antigen-presenting molecule. This suggests that the increase in CD1a 





































































Figure 8. Effect of mycobacteria infection during phenotypic maturation of human monocyte- derived 
dendritic cells. Immature human monocyte-derived dendritic cells (imDCs) generated as described in Materials 
and Methods were infected with M. tuberculosis H37Ra GFP (H37Ra) or M. smegmatis GFP (M. smeg) at MOI 1 
or were left uninfected. In order to obtain mature DCs (mDCs) to use as a maturation control, some of the 
uninfected imDCs were stimulated with TNF- α. After one additional day in culture, cells were fixed, stained with 
the indicated Abs and surface maturation markers examined by flow cytometry. (A) Results are represented as 
the mean fluorescence intensities (MFI) for each surface marker. (B) Representative flow cytometry histograms 
show the HLA-DR, CD86 and CD1a expression from immature DCs, mature DCs, imDCs infected M.  smegmatis 
GFP and imDCs infected with M. tuberculosis H37Ra. 
 
 
Histograms were generated by analyzing events from 5,000 living cells A) Histogram plots show the phenotype of DCs derived from BCG-
infected (BCG-DCs), LPS-treated (LPS-DCs), or untreated monocytes (imDCs) at the fifth day of culture (filled histograms) and after 48 h 
of LPS stim- ulation (empty histograms). 
 












 Next, we decided to determine the effect of both M. tuberculosis H37Ra and M. smegmatis 
infection on DC maturation phenotype induced by TNF-α. To this, mature DCs were infected with M. 
tuberculosis H37Ra GFP or M. smegmatis GFP at MOI 1 and the cell surface expression of CD1a, 
CD86 and HLA-DR was assessed by flow cytometry (Figure 9). Infected mDCs phenotype was 
compared with the surface phenotype of uninfected mDCs, used as the control. We observed that 
mDCs infected either with M. tuberculosis H37Ra GFP or M. smegmatis GFP displayed a maturation 
phenotype identical to the control, since almost no changes in surface expression of CD1a, CD86 and 
HLA-DR molecules were observed after infection. These results suggest that, neither M. smegmatis 
nor M. tuberculosis H37Ra appears to interfere with TNF-α-induced DC maturation. This absence of 
effect might be explained by the fact that mDCs lost their ability to internalize bacteria, as observed in 
our previous results by the lower percentage of mDCs infected with GFP-expressing mycobacteria 





















































Figure 9. Effect of mycobacteria infection on the DC maturation phenotype induced by TNF-α 
stimulation. Immature human monocyte-derived dendritic cells (imDCs) generated as described in Materials 
and Methods were stimulated with TNF-α for 1 day to obtain mature DCs (mDCs). mDCs were either left 
uninfected, as a control, or were infected with M. tuberculosis H37Ra GFP (H37Ra) or M. smegmatis GFP     
(M. smeg) at MOI 1 and cultured for additional 24 hours. These cells were then fixed, stained with specific Abs 
for the surface markers indicated and analyzed by flow cytometry, 24 hours post-infection. Results shown are 






3.2. Role of cathepsins during mycobacteria infection of human 
macrophages and dendritic cells   
 
 In the second part of this project, we addressed the role of lysosomal proteases during 
mycobacteria infection of host cells. First, we examined the expression of different cathepsins, in 
primary human macrophages and dendritic cells infected with pathogenic and non-pathogenic 
mycobacteria, to decipher if mycobacteria infection modulates their expression. We focused our 
attention in cathepsin B and S, because they represent two major lysosomal cysteine proteases 
expressed in professional APCs, whose participation in the processing of internalized antigens and/ or 
invariant chain degradation has been described (Nepal et al., 2008). Second, we investigated the 
importance of these same cathepsins on M. tuberculosis intracellular survival. For this purpose, we 
infected THP-1 macrophages silenced for each individual cathepsin, using shRNA lentiviral library, 
and monitor mycobacteria intracellular survival within these cells. 
 
3.2.1. Mycobacterial manipulation of host cathepsins in human macrophages and 
dendritic cells 
  
 To evaluate if mycobacteria is able to modulate the expression of different cathepsins in 
human macrophages and DCs, we generated human resting macrophages (M0) and immature 
dendritic cells (imDCs) and stimulate them with IFN-γ (M1) and TNF-α (mDCs), respectively. Then, 
these cells (non-stimulated and stimulated) were infected with M. tuberculosis H37Rv at MOI 1. One 
day after infection, cathepsin S and B protein levels were assessed by western blot. These results 
were compared with those from uninfected cells but also from cells infected with a non-pathogenic M. 
smegmatis strain. 
 As observed in Figure 10A, while in uninfected macrophages non-stimulated (M0), cathepsin 
S was abundant, the exposure to M. tuberculosis H37Rv bacilli, lead to an almost 2-fold decrease in 
protein levels. In contrast, in M0 infected cells with the non-pathogenic M. smegmatis, cathepsin S 
levels remained practically unchanged. Next, we decided to determine if M. tuberculosis H37Rv 
infection also results in a decrease in cathepsin S induced by IFN-γ-stimulation, since it was reported 
that M. tuberculosis has the ability to interfere with IFN-γ-signaling pathways (Ting et al., 1999). As 
previously described (Chan, 2010), upon IFN-γ stimulation of M0 cells, an increase of cathepsin S was 
observed. Surprisingly, exposure of IFN-γ activated macrophages either to M. tuberculosis H37Rv or 
M. smegmatis bacilli resulted in a drastically decrease in this protease, to a level below the basal 
protein amounts observed in uninfected M0 cells (Figure  10A).  
In DCs non-stimulated (imDCs), cathepsin S protein levels increased either after M. 
tuberculosis H37Rv or M. smegmatis infection (Figure 10B). However, the degree of up-regulation was 
different between both strains. M. smegmatis infected imDCs showed higher levels of this host 
cathepsin than M. tuberculosis H37Rv infected imDCs.  Upon stimulation with TNF-α, we observed 
that DCs exhibited a slightly increase in cathepsin S, whereas M. tuberculosis H37Rv infection 
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strongly enhanced the amount of this protease in TNF-α-stimulated DCs. Infection with M. smegmatis 





The results obtained from cathepsin B western blot analysis, in primary macrophages infected 
with pathogenic and non-pathogenic mycobacteria, were similar to those from cathepsin S, described 
above (Figure 10A). Figure 11A shows that infection of M0 cells with M. smegmatis resulted in levels 
of cathepsin B similar to those from uninfected M0 macrophages, whereas upon infection with M. 
tuberculosis H37Rv, the amount of this protease was specifically reduced (approximately 1.5-fold 
decrease). After infection of IFN-γ-activated macrophages with either M. tuberculosis H37Rv or M. 
smegmatis at MOI 1 (Figure 11A), a clear reduction in cathepsin B protein levels was observed similar 
to those observed for cathepsin S. Conversely, protein levels of cathepsin B, in infected human 
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Figure 10. Manipulation of Cathepsin S expression by different species of mycobacteria. Western Blot 
analysis of Cathepsin S (CathS), in non-stimulated (M0) and IFN-γ stimulated (M1) human monocyte-derived 
macrophages (A) and in non-stimulated (imDCs) and TNF-α stimulated (mDCs) human monocyte-derived 
dendritic cells (B), 24 hours after infection with M. smegmatis (M. smeg) or M. tuberculosis H37Rv (M. tb H37Rv) 
at MOI 1. β –Tubulin (β –Tub) was used as a normalization control. Quantification of western blots is shown on 
the right. Results are represented as the percentage of relative protein expression comparatively to cathepsin 
expression in uninfected non-stimulated macrophages or dendritic cells.  
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smegmatis or M. tuberculosis H37Rv infection of either imDCs or mDCs, the expression of cathepsin 







Altogether, these results indicate that M. tuberculosis H37Rv infection, contrary to that one of 
M. smegmatis, led to a reduction in basal cathepsin S and B protein levels in M0 macrophages, while 
in IFN-γ-activated macrophages, exposure to both M. tuberculosis H37Rv and M. smegmatis strains 
resulted in a dramatic decrease in protein amounts of these lysosomal proteases. Furthermore, in 
mature DCs, M. tuberculosis H37Rv infection led to a strong increase in cathepsin S contrary to 
cathepsin B. M. smegmatis seems to enhance cathepsin S expression both in imDCs and mDCs, 
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Figure 11. Manipulation of Cathepsin B expression by different species of mycobacteria. Western Blot 
analysis of Cathepsin B (Cath B), in non-stimulated (M0) and IFN-γ stimulated (M1) human monocyte-derived 
macrophages (A) and in non-stimulated (imDCs) and TNF-α stimulated (mDCs) human monocyte-derived 
dendritic cells (B), 24 hours after infection with M. smegmatis (M. smeg) or M. tuberculosis H37Rv (M. tb 
H37Rv) at MOI 1. β –Tubulin (β –Tub) was used as a normalization control. Quantification of western blots is 
shown on the right. Results are represented as the percentage of relative protein expression comparatively to 
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3.2.2. Effect of cathepsins on M. tuberculosis intracellular survival within THP-1 
macrophages  
 
Next, we examined the importance of these host proteases on the pathogen intracellular 
survival within macrophages. To accomplish this, a shRNA lentiviral library was used, to express 
specific short hairpin RNAs (shRNAs), in order to knockdown cathepsin S and B in primary human 
macrophages and dendritic cells. However, in these cells, this silencing technique was not successful 
(data not shown), probably as a result of problems in spinoculation conditions. So, to proceed with this 
experiment, we decided to apply this same silencing method, to THP-1 monocytes instead of primary 
human cells, since it’s a well-studied human monocytic cell line, whose gene silencing using shRNA 
lentiviral vectors was already optimized in our laboratory. 
After production of lentivirus expressing cathepsin B-shRNA oligomers, cathepsin S-shRNA 
oligomers or control shRNA oligomers, THP-1 monocytes were transduced with these vectors, in order 
to stably knockdown cathepsin S or B genes. Transduced cells were selected with 5 µg/ml puromycin 
and then, differentiated into macrophages by incubation with PMA overnight. THP-1 macrophages 
silenced for cathepsin S or B were then infected with M. tuberculosis H37Rv at MOI 1 (to avoid 
macrophages extensive cell death during the course of the experiment). To monitor the effect of 
knockdown of these genes on mycobacteria intracellular survival, CFU were determined at day 5 post-
infection. Transduced cells were also infected with the avirulent M. tuberculosis H37Ra strain, at the 
same MOI and the results compared with those from virulent M. tuberculosis H37Rv.  
 To test cathepsin S silencing efficiency, in THP-1 macrophages transduced with different 
shRNA lentivirus, the levels this cathepsin were quantified by western blot. As shown in Figure 12B, 
expressed shRNA 2 and 3 considerably reduced cathepsin S levels in THP-1 macrophages while 
shRNA 1 did not significantly decrease cathepsin S levels. We observed that (Figure 12A) cathepsin S 
knockdown either of approximately 94% (shRNA 2) or 87% (shRNA 3) resulted in a significant 
increase in M. tuberculosis H37Ra CFUs. Strikingly, silencing of cathepsin S using the same shRNAs 
did not alter significantly M. tuberculosis H37Rv survival in comparison with the control. In 
macrophages transduced with the shRNA 1, either M. tuberculosis H37Ra or M. tuberculosis H37Rv 
survival was similar to the control. This result is consistent with the fact that shRNA 1 did not 
significantly knockdown cathepsin S, which means that the differences observed in the intracellular 
survival of M. tuberculosis H37Ra and M. tuberculosis H37Rv, when the other shRNAs were used, 
were in fact due to the absence of cathepsin S in macrophages.  
Taken together, these data suggest that the knockdown of cathepsin S leads to increased 
survival of M. tuberculosis H37Ra in THP-1 macrophages, while does not seem to interfere with M. 
tuberculosis H37Rv survival. This absence of effect as a result of cathepsin S knockdown, might be 
explained by the fact that M. tuberculosis H37Rv already downregulates cathepsin S expression in 
human macrophages, as demonstrated by our previous results (Figure 10A). Therefore, cathepsin S 
















As shown in Figure 13B, transduction of THP-1 cells with shRNA 1 and 2, drastically decrease 
cathepsin B protein amounts (Figure 13B). shRNA 1 decreased cathepsin B levels around 89% and 
shRNA 2 reduced around 81%. Silencing of cathepsin B significantly increased the bacterial burden, in 
THP-1 macrophages infected either with M. tuberculosis H37Ra or M. tuberculosis H37Rv (Figure 
13A). However, the cathepsin B knockdown appears to enhance the survival of M. tuberculosis H37Ra 
to a higher extent than that one of M. tuberculosis H37Rv.   
 These observations indicate that cathepsin B might be relevant to the control of both M. 
tuberculosis H37Rv and M. tuberculosis H37Ra intracellular growth, which is consistent with our 
previous results that showed that M. tuberculosis H37Rv down-regulates cathepsin B protein levels 
















































































































Figure 12. Effect of Cathepsin S (Cath S) silencing on M. tuberculosis H37Ra and M. tuberculosis H37Rv 
intracellular survival within THP-1 macrophages. (A) THP-1 monocytes, transduced with lentiviral vectors that 
expressed short-hairpin RNAs (shRNAs) specific for cathepsin S (shRNA 1, 2 and 3) or control shRNA, were 
differentiated into macrophages by incubation with PMA overnight, followed by infection with M. tuberculosis 
H37Ra or M. tuberculosis H37Rv at MOI of 1. To measure mycobacteria intracellular survival CFU were 
determined at day 5 post-infection. Data are expressed as the mean percentage of CFU relative to control shRNA 
± SD of three replicates from one experiment. (B) Knockdown efficiency of cathepsin S.  Levels of cathepsin S in 
THP-1 macrophages transduced with shRNA 1, 2, 3 and control shRNA were quantified by western blot. β –
Tubulin (β –Tub) was used as a normalization control. Results are represented as the mean percentage of 
relative protein expression comparatively to control ± SD from two independent experiments.  * , statistically 
significant differences comparatively to control shRNA ( * P < 0,05) by One Way ANOVA followed by 
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Figure 13. Effect of Cathepsin B (Cath B) silencing on M. tuberculosis H37Ra and M. tuberculosis H37Rv 
intracellular survival within THP-1 macrophages. (A) THP-1 monocytes, transduced with lentiviral vectors 
that expressed short-hairpin RNAs (shRNAs) specific for cathepsin B (shRNA 1, 2) or control shRNA, were 
differentiated into macrophages by incubation with PMA overnight, followed by infection with M. tuberculosis 
H37Ra or M. tuberculosis H37Rv at MOI of 1. To measure mycobacteria intracellular survival, CFU were 
determined at day 5 post-infection. Data are expressed as the mean percentage of CFU relative to control 
shRNA ± SD of three replicates from one experiment. (B) Knockdown efficiency of cathepsin B.  Levels of 
cathepsin B in THP-1 macrophages transduced with shRNA 1, 2 and control shRNA were quantified by western 
blot. β –Tubulin (β –Tub) was used as a normalization control. Results are represented as the mean percentage 
of relative protein expression comparatively to control ± SD from two independent experiments.  * , statistically 
significant differences comparatively to control shRNA ( * P < 0,05) by One Way ANOVA followed by 
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 An effective immune response to M. tuberculosis involves APCs, such as alveolar 
macrophages and DCs, which represent the first lines of defense encountered by this pathogen, in the 
host. These two cell types have distinct roles in immunity against tuberculosis: while macrophages 
mainly induce microbicidal mechanisms for elimination of mycobacteria, DCs are specialized in the 
presentation of mycobacterial antigens to naïve T cells (Banchereau et al., 2000; Hestvik, Hmama, & 
Av-gay, 2005). Macrophages and DCs must undergo an activation and maturation process, 
respectively, so they can perform their specific functions. Therefore, in the first part of this thesis, we 
investigated whether mycobacteria infection interferes with macrophage activation and dendritic cell 
maturation. For this purpose, we used human macrophages and DCs, obtained by culturing PBMCs in 
vitro with the respective cytokines. These cells acquired morphologic features and a cell surface 
phenotype (Figure 3) that closely resemble resting macrophages (M0) (Smith et al., 1998; Young et 
al., 1990) and immature DCs (Chapuis et al., 1997; Sallusto and Lanzavecchia, 1994). Subsequently, 
we infected resting macrophages and imDCs with GFP-expressing mycobacteria strains. By using 
GFP expressing M. tuberculosis H37Ra and M. smegmatis, we were able to select by flow cytometry 
the cells that have internalized mycobacteria and thus, analyze the effect of infection on the 
expression of their surface activation and maturation markers. 
 Classically activated macrophages (M1) are developed in response to exposure to a microbial 
challenge or in response to type-1 cytokines, of which IFN-γ is probably one of the most relevant 
(Lugo-villarino et al., 2011; Pieters, 2008). It is widely described that IFN-γ has a critical role in 
immunity against intracellular pathogens, such as M. tuberculosis (Cooper et al., 1993; Flynn et al., 
1993; Newport and Huxley, 1996). Considering the importance of IFN-γ-induced activation in the 
control of infection, it is not surprising that M. tuberculosis has evolved mechanisms to interfere with 
induction of this pro-inflammatory M1 phenotype (Benoit et al., 2008), in order to persist within host 
cell. Indeed, our results demonstrate that the infection of M0 macrophages with the avirulent M. 
tuberculosis H37Ra strain appears to prevent the induction of M1 pro-inflammatory phenotype at the 
level of the antigen presenting molecules, despite the low bacterial load used. In contrast, infection 
with the non-pathogenic M. smegmatis was clearly stimulatory of M1 phenotype, almost as effective as 
IFN-γ stimulation. Since the percentage of infected cells with M. tuberculosis H37Ra and with M. 
smegmatis was similar (Figure 4), the marked differences observed may actually be explained by 
virulence mechanisms of M. tuberculosis that does not exist in M. smegmatis. These findings are in 
line with a previous report, showing a slightly down-modulation of the expression of MHC class II 
molecules and no alterations in CD86 molecules, after M. tuberculosis H37Rv infection of human 
monocyte-derived macrophages (Giacomini et al., 2001). This suggests that prevention of induction of 
M1 phenotype at the level of antigen presenting molecules following infection with M. tuberculosis 
H37Ra, possibly impairs the capacity of macrophages to present mycobacterial antigens and thus to 
activate CD4+ T cells.  
 Interestingly, despite preventing the induction of the M1 phenotype, M. tuberculosis H37Ra 
infection did not impair IFN-γ-induced activation of macrophages, at least at the level of antigen 
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presenting molecules (Figure 6). This indicates that the IFN-γ-induced activation was able to 
overcome the inhibitory effects of M. tuberculosis H37Ra infection on antigen presenting molecules 
within M0 macrophages (Figure 5). In contrast, a previous study by Hmama et al. (1998) reported that 
a virulent M. tuberculosis strain decreased IFN-γ-induced cell surface expression of HLA-DR 
molecules in THP-1 cells (Hmama et al., 1998). Another report showed that in murine bone-marrow-
derived macrophages, infection with viable M. tuberculosis H37Ra inhibited IFN-γ-induced expression 
of MHC class II molecules (Noss et al., 2000). We considered that, differences in the mycobacterial 
strain, the type of macrophages and the multiplicity of infection used, might explain this discrepancy 
between our results and those previously reported. The MOI used by Noss et al. (2000) was 
considerably higher than that used in our work, and resulted in inhibition of MHC class II surface 
expression in murine bone-marrow-derived macrophages. Hmama et al. (1998) observed attenuation 
in IFN-γ-induced expression of HLA-DR molecules, using a virulent M. tuberculosis strain while in our 
work we used the avirulent M. tuberculosis H37Ra strain.  
 Altogether, these results lead us to conclude that at a low MOI, M. tuberculosis H37Ra 
infection prevents induction of M1 pro-inflammatory phenotype at the level of the antigen presenting 
molecules but is not sufficient to inhibit the IFN-γ-induced macrophage activation. Taking in 
consideration the stronger bactericidal environment of M1 macrophages, also evidenced by our results 
(Figure 4), we speculate that with such low bacterial load, IFN-γ-induced activation overcomes the 
inhibitory effects employed by the avirulent M. tuberculosis H37Ra.  
 Dendritic cells play a central role in the initiation of a specific T-cell immune response to 
pathogens. Therefore, these most potent APCs are thought to be essential for the control of M. 
tuberculosis infections, by internalizing, processing and presenting mycobacterial antigens to naïve T 
cells in lymph nodes (Mortellaro et al., 2009; Steinman, 1991). The outcome of the interaction between 
pathogenic mycobacteria and DCs is still not completely understood and there are conflicting reports 
within the literature regarding the ability of these pathogens to interfere with DC maturation. In this 
study, we found that the infection of immature DCs with the avirulent M. tuberculosis H37Ra induces 
DC maturation, as evidenced by an up-regulation in surface expression of HLA-DR molecules and co-
stimulatory molecules CD86 (Figure 8). Moreover, as expected (Martino et al., 2005), an enhanced 
expression of these maturation markers was also observed after infection with the non-pathogenic M. 
smegmatis (Figure 8). Despite this, M. tuberculosis H37Ra infection resulted in higher up-regulation of 
HLA-DR and CD86 molecules than that one with M. smegmatis, indicating that both species induce 
maturation of DCs, but the extent of induction is rather higher with M. tuberculosis H37Ra. This may 
be attributed to the fact that M. tuberculosis H37Ra is an avirulent mycobacterium strain highly related 
with the virulent M. tuberculosis H37Rv (Zheng et al., 2008), while M. smegmatis is environmental 
mycobacterium that can infect immune cells but does not persist in professional phagocytes (Jordao et 
al., 2008; Martino et al., 2005). Our results are in agreement with earlier in vitro studies showing that 
human DCs undergo maturation upon infection with different mycobacterial species, such as virulent 
M. tuberculosis (Giacomini et al., 2001) and the attenuated strain M. bovis BCG (Hashimoto et al., 
2002; Kim et al., 1999). Contrasting with these studies and with our results, Hanekon et al. (2003) 
reported that exposure of DCs to M. tuberculosis H37Rv resulted in a minimal phenotypic maturation 
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of imDCs. In our opinion, the reason for the apparent discrepancy observed may lie in the positive 
control for maturation utilized. While we used a single inflammatory cytokine, TNF-α, whose role in 
induction of DC maturation in vitro is well documented (Roake et al., 1995; Sallusto and Lanzavecchia, 
1994), Hanekon et al. (2003) stimulated imDCs with a potent maturation cocktail composed by three 
cytokines, which could have resulted in a higher expression of maturation markers than that from 
infected cells. 
 Taken together, this lead us to speculate that the M. tuberculosis H37Ra induced maturation 
of imDCs, observed in our experiments, perhaps reflects a strategy employed by the mycobacteria, to 
take advantageous of the migratory properties of mDCs, and thus disseminate within the host. On the 
other hand, from the perspective of the host, induction of DC maturation upon M. tuberculosis H37Ra 
infection could contribute to enhanced presentation of mycobacterial antigens and thus, this infected 
DCs could constitute potent stimulators of T cell response against this mycobacterium.  
 In addition to the classical MHC class II and I presentation pathway, DCs can also present 
lipid antigens to T cells, in the context of CD1 molecules (Crevel et al., 2002). Considering the lipid 
content of mycobacteria cell wall, we decided to analyze the effect of infection on the expression of 
CD1a molecules in imDCs. We observed that both M. tuberculosis H37Ra and M. smegmatis 
infections induced a similar up-regulation of these antigen presenting molecules. These results 
suggest that the increase in CD1a expression appears to be independent of the differences in 
virulence between both species. Previous studies (Stenger et al., 1998) revealed that the virulent M. 
tuberculosis H37Rv strain is able to down-regulate expression of CD1a molecules on the surface of 
monocytes co-cultured with GM-CSF and IL-4. It can be hypothesize that the down-regulation of CD1a 
reflects a further mechanism induced by pathogenic mycobacteria to circumvent immune recognition, 
that the avirulent M. tuberculosis strain H37Ra, might not be able to induce, even being highly related 
to M. tuberculosis H37Rv (Zheng et al., 2008).  
 We have also analyzed the effect of M. tuberculosis H37Ra and M. smegmatis infection on DC 
maturation phenotype induced by TNF-α treatment prior to infection. Our results showed that neither 
M. smegmatis nor M. tuberculosis H37Ra appears to interfere with TNF-α-induced DC maturation 
(Figure 9). This probably results from the fact that DCs stimulated with TNF-α, acquire a mature 
phenotype and thus, loss the ability to internalize bacteria (Sallusto and Lanzavecchia, 1994). Indeed, 
we observed that the percentage of TNF-α stimulated DCs infected with mycobacteria was extremely 
reduced in comparison imDCs (Figure 7), which confirms these previous results. Assuming that mDCs 
almost did not internalize either M. smegmatis or M. tuberculosis H37Ra species, it’s reasonable that 
no alterations in the phenotypic maturation of mDCs were observed. 
 Concluding this part of the thesis, it was demonstrated that the outcome of infection of 
macrophages and DCs differs with the non-pathogenic M. smegmatis and with the avirulent M. 
tuberculosis H37Ra. Moreover, it was interesting to observe that the infection with the avirulent M. 
tuberculosis strain induced distinct phenotypes according to the host cell type. This is probably 
connected with the different roles of these host cells in immunity against pathogens. In human 
macrophages that act as key effector cells in mycobacterial killing and antigen presentation at the site 
of infection, M. tuberculosis H37Ra prevents the induction of M1 pro-inflammatory phenotype at the 
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level of the antigen presenting molecules. This means that this mycobacterium probably manipulates 
these cells towards an anti-inflammatory phenotype. In future studies, the specific activation markers 
of M2 phenotype should be analyzed in infected cells, in order to support this theory. In human DCs, 
host cells responsible for mycobacterial antigen presentation to naïve T cells in the lymph nodes, the 
infection with M. tuberculosis H37Ra induces DC maturation. In this case we speculate that M. 
tuberculosis H37Ra-induced DC maturation might offer the possibility to the bacilli to use these cells 
as a vehicle to reach the lymph nodes and maybe other organs. On the other hand, the induction of 
this phenotype might also represent a defense mechanism of the host by which is initiated a specific 
T- cell immune response. Since maturation does not necessarily implicates that the cell is functionally 
capable of presenting antigen to T cells, it would be interesting, in a near future, to examine the 
capacity of M. tuberculosis H37Ra infected DCs to induce antigen specific T cell proliferation as well 
as to analyze the profile of secreted cytokines by infected cells.  
 
 Cathepsins are essential to the antigen presenting function of macrophages and DCs, and 
thus, to the effective CD4+ T cell immune response against pathogens, such as M. tuberculosis. It was 
previously reported that M. tuberculosis modulates MHC class II antigen presentation (Hmama et al., 
1998; Noss et al., 2000; Pancholi et al., 1993) and that one of the mechanisms underlying this 
attenuation, is the modulation of host cathepsins that participate in this pathway (Nepal et al., 2006). 
Therefore, in the second part of this thesis, we aimed to decipher the role of cathepsins during 
mycobateria infection of human monocyte-derived macrophages and DCs. We focused in cathepsin S 
and B, two major lysosomal cysteine proteases expressed in professional APCs, and involved in the 
MHC class II pathway for antigen presentation (Hsieh et al., 2012).  
 Cathepsin S plays an important role in MHC class II antigen presentation, being the main 
cysteine protease responsible for the late steps of invariant chain (Ii chain) degradation, in 
macrophages and DCs (Chapman, 2006; Riese et al., 1996).  
 Our results, concerning human macrophages, demonstrate that M. tuberculosis H37Rv 
infection, contrary to M. smegmatis infection, lead to a reduction of basal cathepsin S protein levels in 
these cells (Figure 10A). Since cathepsin S mediates the final steps of the Ii chain cleavage, this 
suggest that the decrease of this protease levels, probably results in a defect in Ii chain processing in 
infected macrophages. Indeed, it was previously described that infection of THP-1 macrophages with 
M. bovis BCG was associated with a reduction of Ii chain degradation and subsequent export of 
immature MHC class II molecules to the cell surface (Sendide et al., 2005). Therefore, we hypothesize 
that the virulent M. tuberculosis H37Rv strain by decreasing cathepsin S protein levels, probably 
attenuates the surface expression of mature MHC class II molecules. Surprisingly, infection either with 
M. tuberculosis H37Rv or M. smegmatis resulted in a drastic decrease in IFN-γ-induced cathepsin S 
protein levels in human macrophages (Figure 10A). We speculate that cathepsin S levels in IFN-γ-
activated macrophages appear to be modulated by an intrinsic property of mycobacterial species. This 
property does not seem to be related with mycobacterial virulence, since both M. tuberculosis H37Rv 
and M. smegmatis down-regulate IFN-γ-induced cathepsin S expression, but the former is a virulent 
species and the latter a non-pathogenic one. A previous study, describing the ability of the attenuated 
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strain M. bovis BCG to inhibit IFN-γ-induced cathepsin S expression in human macrophages (Sendide 
et al., 2005), represents an evidence that supports this hypothesis.  
 Interestingly, in dendritic cells when we analyzed the expression of cathepsin S upon 
mycobacteria infection (Figure 10B), clear differences were observed in comparison with human 
macrophages. In both imDCs and mDCs, cathepsin S protein levels increased upon M. smegmatis 
and M. tuberculosis H37Rv infection. However, infection with M. tuberculosis H37Rv, in immature DCs 
resulted in a minimal increase of cathepsin S levels, while in mature DCs strongly increased this 
protease levels. Although we have no clear explanation for these results, it can be hypothesize that in 
imDCs, the virulent M. tuberculosis H37Rv strain prevents the up-regulation of cathepsin S levels and 
thus, might impair the Ii chain processing, as previously observed in human macrophages (Sendide et 
al., 2005). Although M. tuberculosis H37Rv infection of imDCs results in an increase in expression of 
antigen-presenting molecules, as a result of M. tuberculosis H37Rv-induced maturation (Henderson et 
al., 1997), it might be an increase in immature MHC class II molecules instead of peptide-loaded MHC 
class II molecules. On the other hand, TNF-α-induced maturation appears to overcome this inhibitory 
effect employed by M. tuberculosis H37Rv, and thus, a strong increase in this protease levels is 
observed.   
 Soualhine and co-authors (2007) proposes that active cathepsin S have a direct role in 
abolishing mycobacterial control of phagosome-lysosome fusion, although its underlying mechanism is 
still unclear. This study demonstrated, that infection of macrophages with a BCG strain engineered to 
secrete active cathepsin S, accelerates fusion of its phagosomes with lysosomes which leads to 
intracellular killing and in turn, to an increase in antigen presentation by infected macrophages 
(Soualhine et al., 2007). Rather than over-expressing cathepsin S in host cells by using an engineered 
mycobacterium, we decided to knockdown this protease in THP-1 macrophages, by using shRNA 
lentiviral vectors, in order to understand its influence on M. tuberculosis intracellular survival. We found 
that the silencing of cathepsin S in macrophages significantly increases intracellular survival of the M. 
tuberculosis H37Ra strain while does not interfere with intracellular survival of the M. tuberculosis 
H37Rv strain (Figure 12). These findings may reflect differences in virulence between both strains. 
The virulent M. tuberculosis H37Rv strain, as demonstrated in our results (Figure 10A), has the 
capacity to manipulate cathepsin S in human macrophages, by diminishing its protein levels. 
Therefore, no alterations on intracellular survival were observed, probably because we were mimicking 
this subversion mechanism employed by M. tuberculosis H37Rv, when we silenced cathepsin S in 
macrophages. On the other hand, the significantly increase on survival of the avirulent M. tuberculosis 
H37Ra strain reveals that this protease probably plays an important role in the control of M. 
tuberculosis H37Ra intracellular growth in human macrophages. Therefore, we conclude that 
cathepsin S might be involved in the control of M. tuberculosis intracellular growth, but while the 
virulent M .tuberculosis H37Rv developed a mechanism to avoid the effect of this protease, the 
avirulent M. tuberculosis H37Ra might not have the same manipulation mechanism or might have but 
is less effective than that of M. tuberculosis H37Rv.  
 Prior to CD4+T cell activation, exogenous antigens must be processed by lysosomal 
proteases to generate antigenic peptides for presentation via MHC class II molecules (Zhang et al., 
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2000). Cathepsin B which is mainly expressed in APCs has been proposed to be one of the lysosomal 
proteases involved in this process (Matsunaga et al., 1993; Mizuochi et al., 1994).  
 In the present work, concerning human macrophages, we found that infection of these cells 
with M. tuberculosis H37Rv decreases basal cathepsin B protein levels, while infection with the non-
pathogenic M. smegmatis has no effect on this protease (Figure 11A). This suggests that the 
reduction in basal cathepsin B levels probably represents a specific subversion mechanism employed 
by pathogenic mycobacteria, since infection with the non-pathogenic M. smegmatis shows no 
alterations in this protease levels. Considering the key role of cathepsin B in antigen processing (Mort 
and Buttle, 1997), it can be speculate that the decrease in cathepsin B levels upon mycobacteria 
infection may interfere with the generation of protective T cell epitopes. Very little information exists on 
the role of cathepsin B during mycobacteria infection. One study by Rivera-Marrero et al. (2004) 
showed that the maturation of human THP-1 monocytes upon exposure to a virulent M. tuberculosis 
strain resulted in an increased expression of cathepsin B. It can be speculated that the discrepancy 
observed between this report and our work, might be explained by a differential modulation of 
cathepsin B levels by M. tuberculosis in human monocytes and M0 macrophages, probably according 
to the role of this protease in each host cell during infection. When we analyzed cathepsin B 
expression in infected macrophages previously activated with IFN-γ, we observed a strong decrease 
in the protease levels in either M. tuberculosis H37Rv or M. smegmatis infected cells. This drastic 
reduction of IFN-γ-induced cathepsin B levels may be caused by an inherent property common to 
several mycobacterial species and not necessarily related to virulence. 
 Concerning human DCs, we also analyzed the effect of mycobacteria infection on cathepsin B 
protein levels. Upon M. smegmatis or M. tuberculosis H37Rv infection of either imDCs or mDCs, the 
expression of cathepsin B remained unchanged relative to uninfected control (Figure 11B). Therefore, 
these results suggest that mycobacteria infection probably does not interfere with the protein 
expression of this lysosomal protease in dendritic cells.  
 In our work, we proposed to determine whether the down-regulation of cathepsin B would be 
relevant to M. tuberculosis intracellular survival in macrophages. Thus, we silenced this cathepsin in 
THP-1 macrophages, by using a shRNA lentiviral library. Our results demonstrate that the knockdown 
of cathepsin B significantly increases intracellular survival of M. tuberculosis H37Ra but also M. 
tuberculosis H37Rv. These findings suggest that cathepsin B might be important to the control of both 
strains intracellular growth in macrophages. The fact that the virulent M. tuberculosis H37Rv 
decreases the levels of cathepsin B (Figure 11A) also supports this hypothesis. We possibly observed 
an increased survival of this virulent strain when comparing to the control because cathepsin B down-
regulation observed upon M. tuberculosis H37Rv infection might not be enough to overcome the 
effects of this protease in the control of intracellular growth.  
  In conclusion, it was demonstrated that M. tuberculosis modulates cathepsin S and B 
differentially of the non-pathogenic M. smegmatis. Furthermore, during mycobacteria infection 
cathepsin S and B levels appear to be specific of the host cell type being infected. This might be 
related with different kinetics of acidification and proteolytic activity existent between these cells 
(Trombetta and Mellman, 2005). At the same time, evidences point for a role of both cathepsins in the 
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control of intracellular growth of M. tuberculosis H37Ra and M. tuberculosis H37Rv strains within 
macrophages. However, the virulent M. tuberculosis H37Rv strain appears to be capable to subvert 
the negative effects of cathepsin S on the intracellular survival, by decreasing their protein levels. On 
the other hand, the avirulent M. tuberculosis H37Ra strain appears to be more susceptible to the 
killing effects of both cathepsins. Future studies evaluating cathepsin S and B activity in macrophages 
and dendritic cells after mycobacteria infection, may contribute to a better understanding of the 
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